Kooperativer Bibliotheksverbund

UID:

Format: 1 online resource (164 pages)

Edition: 1st ed.

ISBN: 9783031579608

Series Statement: SpringerBriefs in Archaeology Series

Note: Intro -- Foreword -- Contents -- Abbreviations -- Chapter 1: Potentially Polluting Wrecks: An Introduction -- 1.1 Overview -- 1.2 RUST, RULET, and the Potentially Polluting Wrecks Study -- 1.3 Site Assessment and Pollution Risk Remediation -- 1.4 Protecting Our Ocean Heritage -- References -- Chapter 2: Potentially Polluting Wrecks and the Legal Duty to Protect Our Ocean Heritage -- 2.1 Introduction -- 2.2 The Initial Evolution of a Duty to Protect Our Ocean Heritage -- 2.2.1 1972 Stockholm Declaration -- 2.2.2 The World Heritage Convention Integrating the Conservation of Cultural and Natural Heritage -- 2.3 The 1982 Law of the Sea Convention: The General Legal Framework for Managing PPWs -- 2.3.1 General Provisions on the Duty to Protect the Marine Environment and PPWs -- 2.3.2 Articles Protecting Cultural Heritage Found at Sea (303) and in the Area (149) -- 2.4 Maritime Law Conventions and the Ocean Heritage: The IMO Endeavours -- 2.4.1 Natural Disasters by Human Activities -- 2.4.2 Cultural Disasters by Human Greed -- 2.4.3 The Wreck Removal Convention -- 2.5 A New Approach to Ocean Heritage -- 2.5.1 The Precautionary Approach as a Guide to Manage PPWs as UCH -- 2.5.2 2001 Convention on the Protection of Underwater Cultural Heritage -- 2.5.3 The Question of PPWs Which Are Both UCH and Warships or Other States Vessels -- 2.6 Conclusion -- References -- Chapter 3: Environmental Impact and Modeling of Petroleum Spills -- 3.1 Introduction -- 3.2 Background -- 3.3 Previous Work -- 3.4 Released Oil -- 3.5 Computational Spill Models -- 3.6 Acute Biological Effects -- 3.7 Seasonal Considerations -- 3.8 Validation Studies -- 3.9 Stochastic Assessments -- 3.10 Conclusions -- References -- Chapter 4: Corrosion Processes of Steel-Hulled Potentially Polluting Wrecks -- 4.1 Overview -- 4.2 Corrosion Types in Shipwrecks. , 4.3 OCP and General Corrosion Factors -- 4.4 Acute Environmental Factors -- 4.5 Cyclical Environmental Factors -- 4.6 Long-Term Environmental Factors -- 4.7 Anthropogenic Factors -- 4.8 Ship Construction, Condition, Impact, and Orientation -- 4.9 A History of Shipwreck Corrosion Analysis -- 4.10 Case Study: USS Arizona -- 4.11 Conclusion -- References -- Chapter 5: From Desktop to Dive: Assessing the Pollution Potential of SS Fernstream, USNS Mission San Miguel and SS Coast Trader -- 5.1 Introduction -- 5.2 SS Fernstream -- 5.3 USNS Mission San Miguel -- 5.4 SS Coast Trader -- 5.5 Conclusion -- References -- Chapter 6: Managing Potentially Polluting Wrecks in the United Kingdom -- 6.1 The Inception of Wreck Management in the UK -- 6.2 Current Wreck Management in the UK -- 6.3 Distribution of British PPW -- 6.4 Wreck Survey Techniques -- 6.5 Case Studies -- 6.5.1 RFA Darkdale -- 6.5.2 RFA War Mehtar -- 6.5.3 SS Derbent -- 6.5.4 HMS Prince of Wales and HMS Repulse -- 6.6 Summary -- References -- Chapter 7: Polluting Wrecks in the Baltic Sea -- 7.1 Introduction -- 7.2 History of Operations -- 7.3 Wrecks in the Baltic Region -- 7.4 Sweden -- 7.5 Finland -- 7.6 Russia -- 7.7 Estonia -- 7.8 Latvia -- 7.9 Lithuania -- 7.10 Poland -- 7.11 Germany -- 7.12 Denmark -- 7.13 Wreck Risk Assessment Methods -- 7.14 Case Studies of the Stuttgart and Franken Wrecks -- 7.14.1 SS Stuttgart -- 7.15 Supply Vessel Franken (Trossschiff Franken) -- 7.16 Conclusion -- References -- Chapter 8: Potentially Polluting Wrecks in the Blue Pacific -- 8.1 Introduction to Potentially Polluting Wrecks in the Pacific -- 8.2 History of PPW Management in the Pacific -- 8.3 U.S Government PPW Interventions in the Pacific -- 8.4 USS Mississinewa -- 8.5 Ex-USS Chehalis -- 8.6 Ex-USS Prinz Eugen -- 8.7 Japanese Government Interventions in the Pacific. , 8.8 Current Situation of PPW in the Pacific -- 8.9 Case Study: Potentially Polluting Wrecks in Chuuk Lagoon -- 8.10 The FSM WWII Shipwreck Pollution Mitigation Project -- 8.11 Lessons and Conclusions -- References -- Chapter 9: Satellite Detection and the Discovery of Bloody Marsh -- 9.1 Introduction -- 9.2 SS Bloody Marsh -- 9.3 Initial Expedition -- 9.4 Satellite Detection of Sea Surface Oil Slicks -- 9.5 Oil Slick Evidence Towards Bloody Marsh Wreck Location -- 9.6 Discovery -- 9.7 Discussion and Conclusion -- References -- Chapter 10: Searching for a Lost PPW: SS William Rockefeller -- 10.1 Introduction -- 10.2 Why Bayesian Search? -- 10.3 Searching for Rockefeller -- 10.4 Conclusion -- References -- Chapter 11: Assessment Methodologies for Potentially Polluting Wrecks: The Need for a Common Approach -- 11.1 Introduction -- 11.2 Current Status of Wreck Assessment Methods -- 11.3 Our Experience in the Assessment of Potentially Polluting Wrecks -- 11.4 Case Study: Tug Simson -- 11.4.1 Case Study: Emergency Response Assessment -- 11.5 Wreck Assessment Methodologies-The Future -- References -- Chapter 12: Concluding Statement.

Additional Edition: Print version: Brennan, Michael L. Threats to Our Ocean Heritage: Potentially Polluting Wrecks Cham : Springer,c2024 ISBN 9783031579592

Language: English

Keywords: Electronic books.

URL: Click to View

URL: Volltext  (kostenfrei)

URL: Volltext  (kostenfrei)

URL: lizenzpflichtig

UID:

Format: 1 Online-Ressource (454 Seiten)

Edition: 3rd ed

ISBN: 9783648152454

Series Statement: Haufe Fachbuch

Note: Description based on publisher supplied metadata and other sources , Intro -- Inhaltsverzeichnis -- Hinweis zum Urheberrecht -- Impressum -- Grußwort des Verbandes der Immobilienverwalter Deutschland (VDIV) -- Vorwort der Vonovia Immobilien Treuhand -- Vorwort der Autoren -- Abkürzungsverzeichnis -- 1 Der Verwalter -- 1.1 Auf der Suche nach einem neuen Verwalter -- 1.2 Die Person des Verwalters - wer darf überhaupt »verwalten«? -- 1.3 Die Qualifikation des Verwalters -- 1.4 Welche Gesetze muss der Verwalter kennen? -- 1.5 Für welchen Zeitraum kann ein Verwalter bestellt werden? -- 1.6 Vorsicht bei der Formulierung des Bestellungsbeschlusses -- 1.7 Der Verwaltervertrag: Was regelt der Vertrag? -- 1.8 Wer darf den Verwaltervertrag unterschreiben? -- 1.9 Der Verwaltervertrag: Was ist eine »AGB-Inhaltskontrolle«? -- 1.10 Welche Vergütungen darf der Verwalter vereinbaren? -- 1.11 Bescheinigung gem. 35a EStG als besondere Leistung? -- 1.12 Wann ist die Verwaltervergütung fällig? -- 1.13 Vorsicht bei »Verträgen zulasten Dritter«! -- 1.14 Sind Vergleichsangebote bei der Verwalterbestellung notwendig? -- 1.15 Stimmrechtsverbot bei der Verwalterbestellung -- 1.16 Stimmrechtsverbot bei Verwalterbestellung bei Vorliegen von Vollmachten -- 1.17 Der Versammlungsleiter bei juristischen Personen -- 1.18 Darf der Verwalter das Grundbuch einsehen? -- 1.19 Gibt es eine Pflicht zur Übersendung von Verwaltungsunterlagen? -- 1.20 Welche Auskunftspflichten treffen den Verwalter? -- 1.21 Beschlussumsetzung -- 1.22 Darf der Verwalter Provisionen vereinnahmen? -- 1.23 Wiederbestellung vergessen - was nun? -- 1.24 Verwalterwechsel: Wer ist für die Erstellung der Jahresabrechnung zuständig? -- 1.25 Der Verwalter als Makler: Vermittlung von Mietwohnungen? -- 1.26 Der Verwalter als Makler: Verkauf und Verwalterzustimmung -- 1.27 Der Verwalter als Baufachmann? -- 1.28 Muss der Verwalter eine Fördermittelberatung durchführen? , 1.29 Kontoführung in der WEG (Legitimation) -- 1.30 Kann der Verwalter seine Immobilienverwaltung verkaufen? -- 1.31 Datenschutz in der WEG - was darf der Verwalter mitteilen? -- 1.32 Hat der Verwalter einen Anspruch auf Entlastung? -- 1.33 Darf der Verwalter Unterlagen der WEG vernichten? -- 1.34 Digitale Beleg- bzw. Rechnungsprüfung? -- 1.35 Keine außerordentliche Abberufung des Verwalters mehr? -- 1.36 Kann der Verwalter sein Amt auch niederlegen? -- 2 Die Vertretung der Wohnungseigentümergemeinschaft -- 2.1 Die Vertretungsmacht des Verwalters im Außenverhältnis -- 2.2 Die Vertretungsmacht des Verwalters im Innenverhältnis -- 2.3 Maßnahmenkatalog durch Beschluss -- 2.4 Beiratsvorsitzender oder Eigentümer als Vertreter -- 2.5 Kompetenzüberschreitung und Haftung des Verwalters -- 2.6 Die Abwicklung von Versicherungsschäden -- 2.7 Die Beauftragung eines Rechtsanwalts in Passivprozessen -- 2.8 Die Beauftragung eines Rechtsanwalts in Aktivprozessen und Vergütungsvereinbarung -- 2.9 Die verwalterlose WEG -- 3 Verkehrssicherung -- 3.1 Die Erfüllung der Verkehrssicherungspflicht und die Haftung -- 3.2 Kann die Verkehrssicherungspflicht übertragen werden? -- 4 Die Wohnungseigentümer und andere Beteiligte -- 4.1 Der Wohnungseigentümer -- 4.2 Die Haftung des Wohnungseigentümers im Außenverhältnis -- 4.3 Notgeschäftsführung - welche Rechte hat der Eigentümer? -- 4.4 Angemessener Ausgleich für Beschädigungen am Sondereigentum -- 4.5 Wann hat der Eigentümer Anspruch auf Schadensersatz? -- 4.6 Der Anspruch des Eigentümers auf ordnungsmäßige Verwaltung -- 4.7 Ist eine Erhaltungsmaßnahme durch den Eigentümer ohne Beschluss möglich? -- 4.8 Können die Vorschüsse (Hausgeld) gekürzt werden (hier: Verwaltervergütung)? -- 4.9 Muss die WEG zwingend einen Verwaltungsbeirat bestimmen? -- 4.10 Wie viele Personen dürfen in den Verwaltungsbeirat gewählt werden? , 4.11 Was darf der Verwaltungsbeirat entscheiden? -- 4.12 Wann haftet der Verwaltungsbeirat? -- 4.13 Sonderausschüsse in der WEG-Verwaltung? -- 4.14 Kann ein Mieter Verwaltungsbeirat werden? -- 4.15 Darf dem Verwaltungsbeirat ein Gehalt gezahlt werden? -- 4.16 Wer bestimmt den Vorsitzenden des Verwaltungsbeirats? -- 4.17 Können nur natürliche Personen in den Verwaltungsbeirat gewählt werden? -- 4.18 Wie lange ist der Verwaltungsbeirat im Amt? -- 4.19 Muss der Verwaltungsbeirat auch entlastet werden? -- 4.20 Ist der Zwangsverwalter ein neuer Eigentümer? -- 4.21 Die Abschaffung des Ersatzzustellungsvertreters -- 4.22 Duldungspflichten Dritter -- 5 Eigentümerwechsel -- 5.1 Der Regelfall -- 5.2 Der Erbfall -- 5.3 Die Zwangsversteigerung -- 5.4 Ist ein Erwerber an Beschlüsse gebunden? -- 5.5 Ist ein Erwerber an Vereinbarungen gebunden? -- 5.6 Veräußerungszustimmung - wichtige Gründe -- 5.7 Veräußerungszustimmung - Delegation an die Eigentümer -- 5.8 Veräußerungszustimmung - Zeitpunkt der Zustimmungserteilung -- 5.9 Eigentümerwechsel - wie ist mit den angepassten Vorschüssen der erstellten Jahresabrechnung umzugehen? -- 5.10 Eigentümerwechsel - muss eine anteilige Jahresabrechnung erstellt werden? -- 6 Die Lehre von den Beschlüssen -- 6.1 Die Jahrhundertentscheidung des BGH -- 6.2 Beschlusskompetenz: Leistungspflichten -- 6.3 Beschlusskompetenz: Verbot der Tierhaltung? -- 6.4 Beschlusskompetenz: Stimmrechtsausschluss bei Hausgeldrückstand? -- 6.5 Beschlusskompetenz: Mitspracherecht des Eigentümers -- 6.6 Beschlusskompetenz: Umzugskostenpauschale -- 6.7 Der »Tod« der Öffnungsklausel: Belastungsverbot -- 6.8 Abdingbarkeit von Stimmenmehrheiten möglich? -- 6.9 Der Umlaufbeschluss - wie praxistauglich ist er? -- 6.10 Der Umlaufbeschluss - mit einfacher Mehrheit möglich? -- 6.11 Woraus ergeben sich die Beschlusskompetenzen und -mehrheiten im WEG? , 6.12 Anfechtung von Beschlüssen - ein Monat sind nicht vier Wochen -- 6.13 Der Zweitbeschluss -- 6.14 Beschlusskompetenz: Instandsetzung von Fenstern -- 6.15 Ist eine Änderung der Gemeinschaftsordnung durch Beschluss möglich? -- 6.16 Öffnungsklausel in der Gemeinschaftsordnung -- 6.17 Öffnungsklausel - Eintragung von Beschlüssen in das Grundbuch? -- 6.18 Öffnungsklausel - Berechnung der Mehrheit? -- 6.19 »Vergemeinschaftung« von Ansprüchen durch Beschluss -- 6.20 Die Beschluss-Sammlung -- 7 Die Eigentümerversammlung -- 7.1 Einladungsfrist: Drei Wochen sind nicht drei Wochen! -- 7.2 Wer lädt zur Eigentümerversammlung ein? -- 7.3 Ein Nichtberechtigter lädt zur Eigentümerversammlung ein - was nun? -- 7.4 Wer muss zur Eigentümerversammlung eingeladen werden? -- 7.5 Die nicht unterschriebene Einladung zur Eigentümerversammlung -- 7.6 Die Einladung wird nicht zugestellt - was nun? -- 7.7 Ist eine außerordentliche Eigentümerversammlung kostenlos? -- 7.8 Die Uhrzeit der Eigentümerversammlung -- 7.9 Der Ort der Eigentümerversammlung -- 7.10 Eigentümerversammlung in der Wohnung des Verwalters? -- 7.11 Darf die Eigentümerversammlung im Biergarten stattfinden? -- 7.12 Wer führt den Versammlungsvorsitz? -- 7.13 Bye-bye Beschlussfähigkeit -- 7.14 Vorsicht bei Stimmrechtsverboten -- 7.15 Abstimmung: Kann eine abgegebene Stimme zurückgezogen werden? -- 7.16 Abstimmung: Welche Abstimmungsmethoden gibt es? -- 7.17 Muss das Abstimmungsergebnis rechnerisch protokolliert werden? -- 7.18 Enthaltungen - sind das Ja- oder Nein-Stimmen? -- 7.19 Störender Wohnungseigentümer - ist ein Versammlungsausschluss möglich? -- 7.20 Darf der Mieter an der Eigentümerversammlung teilnehmen? -- 7.21 Darf ein Berater bei der Eigentümerversammlung anwesend sein? -- 7.22 Die Tagesordnung -- 7.23 Die Tagesordnung - ist das Nachschieben von Tagesordnungspunkten zulässig? , 7.24 Wie viele Tagesordnungspunkte muss der Verwalter aufnehmen? -- 7.25 Namentliche Abstimmung - aber wann? -- 7.26 Kann sich der Eigentümer von einer beliebigen Person auf der Versammlung vertreten lassen? -- 7.27 Muss zur Eigentümerversammlung eine schriftliche Vollmacht vorgelegt werden? -- 7.28 Müssen sich Ehegatten gegenseitig für die Eigentümerversammlung bevollmächtigen? -- 7.29 Wie viele Vollmachten darf man eigentlich vergeben? -- 7.30 Der Eigentümer als Vollmachtgeber und gleichzeitig Vollmachtnehmer? -- 7.31 Welches Stimmrechtsprinzip gilt? -- 7.32 Versendung der Niederschrift - aber bis wann? -- 7.33 Die Niederschrift - Ergebnis- oder Verlaufsprotokoll? -- 7.34 Wer muss die Niederschrift unterzeichnen? -- 7.35 Unterschriften im Falle einer Doppelfunktion -- 7.36 Verwalternachweis (und qualifizierte Protokollierklausel) -- 7.37 Funktionsbezeichnung in der Niederschrift -- 7.38 Ist auch ein Nachweis für den Vorsitzenden des Beirats notwendig? -- 7.39 Wann besteht ein Anspruch auf Berichtigung der Niederschrift? -- 7.40 Formfehler - ist eine »Heilung« möglich? -- 7.41 Online-Teilnahme an der Eigentümerversammlung? -- 8 Die Finanzen der WEG -- 8.1 Die Kostenverteilung -- 8.2 Änderung des Kostenverteilerschlüssels -- 8.3 Änderung der Kostenverteilung für die Erhaltung der Fenster -- 8.4 Die Öffnungsklausel -- 8.5 Individuelle Pflichten über die GO -- 8.6 Abweichungen von der Heizkostenverordnung -- 8.7 Wirtschaftsplan -- 8.8 Wirtschaftsplan - und die Fälligkeit -- 8.9 Fortgeltung der Vorschüsse -- 8.10 Die Sonderumlage -- 8.11 Die Darlehensaufnahme -- 8.12 Die Kontenführung -- 8.13 Die Jahresabrechnung - Beschlussinhalt -- 8.14 Der Inhalt der Jahresabrechnung -- 8.15 Die Erhaltungsrücklage -- 8.16 Der Umgang mit den Rechtsanwalts- und Verfahrenskosten -- 8.17 Sonderkosten und Einzelbelastung , 8.18 Die bedingte Genehmigung der Anpassung der Vorschüsse

Additional Edition: Erscheint auch als Druck-Ausgabe Füllbeck, Massimo Praxisfälle für WEG-Verwalter Freiburg : Haufe Lexware Verlag,c2021 ISBN 9783648152447

Language: German

Subjects: Economics

Keywords: Deutschland ; Verwalter ; Wohnungseigentum

URL: Volltext  (URL des Erstveröffentlichers)

UID:

Format: 1 online resource (xi, 327 pages) : , digital, PDF file(s).

Edition: 1st ed.

ISBN: 1-108-67051-2 , 1-108-64008-7

Series Statement: Physical Sciences

Content: Instabilities are present in all natural fluids from rivers to atmospheres. This book considers the physical processes that generate instability. Part I describes the normal mode instabilities most important in geophysical applications, including convection, shear instability and baroclinic instability. Classical analytical approaches are covered, while also emphasising numerical methods, mechanisms such as internal wave resonance, and simple `rules of thumb' that permit assessment of instability quickly and intuitively. Part II introduces the cutting edge: nonmodal instabilities, the relationship between instability and turbulence, self-organised criticality, and advanced numerical techniques. Featuring numerous exercises and projects, the book is ideal for advanced students and researchers wishing to understand flow instability and apply it to their own research. It can be used to teach courses in oceanography, atmospheric science, coastal engineering, applied mathematics and environmental science. Exercise solutions and MATLAB® examples are provided online. Also available as Open Access on Cambridge Core.

Note: Title from publisher's bibliographic system (viewed on 19 Apr 2019). , Cover -- Half-title page -- Title page -- Copyright page -- Contents -- Preface -- Acknowledgments -- Part I Normal Mode Instabilities -- 1 Preliminaries -- 1.1 What Is Instability? -- 1.2 Goals -- 1.3 Tools -- 1.4 Numerical Solution of a Boundary Value Problem -- 1.5 The Equations of Motion -- 1.6 Further Reading -- 1.7 Appendix: A Closer Look at Perturbation Theory -- 2 Convective Instability -- 2.1 The Perturbation Equations -- 2.2 Simple Case: Inviscid, Nondiffusive, Unbounded Fluid -- 2.3 Viscous and Diffusive Effects -- 2.4 Boundary Effects: the Rayleigh-Benard Problem -- 2.5 Nonlinear Effects -- 2.6 Summary -- 2.7 Appendix: Waves and Convection in a Compressible Fluid -- 3 Instabilities of a Parallel Shear Flow -- 3.1 The Perturbation Equations -- 3.2 Rayleigh's Equation -- 3.3 Analytical Example: the Piecewise-Linear Shear Layer -- 3.4 Solution Types for Rayleigh's Equation -- 3.5 Numerical Solution of Rayleigh's Equation -- 3.6 Shear Scaling -- 3.7 Oblique Modes and Squire Transformations -- 3.8 Rules of Thumb for a General Shear Instability -- 3.9 Numerical Examples -- 3.10 Perturbation Energetics -- 3.11 Necessary Conditions for Instability -- 3.12 The Wave Resonance Mechanism of Shear Instability -- 3.13 Quantitative Analysis of Wave Resonance -- 3.14 Summary -- 3.15 Appendix: Classical Proof of the Rayleigh and Fjørtoft Theorems -- 3.16 Further Reading -- 4 Parallel Shear Flow: the Effects of Stratification -- 4.1 The Richardson Number -- 4.2 Equilibria and Perturbations -- 4.3 Oblique Modes -- 4.4 The Taylor-Goldstein Equation -- 4.5 Application to Internal Wave Phenomena -- 4.6 Analytical Examples of Instability in Stratified Shear Flows -- 4.7 The Miles-Howard Theorem -- 4.8 Howard's Semicircle Theorem -- 4.9 Energetics -- 4.10 Summary -- 4.11 Further Reading -- 4.12 Appendix: Veering Flows -- 4.13 Appendix: Spatial Growth. , 5 Parallel Shear Flow: the Effects of Viscosity -- 5.1 Conditions for Equilibrium -- 5.2 Conditions for Quasi-Equilibrium: the Frozen Flow Approximation -- 5.3 The Orr-Sommerfeld Equation -- 5.4 Boundary Conditions for Viscous Fluid -- 5.5 Numerical Solution of the Orr-Sommerfeld Equation -- 5.6 Oblique Modes -- 5.7 Shear Scaling and the Reynolds Number -- 5.8 Numerical Examples -- 5.9 Perturbation Energetics in Viscous Flow -- 5.10 Summary -- 6 Synthesis: Viscous, Diffusive, Inhomogeneous, Parallel Shear Flow -- 6.1 Expanding the Basic Equations -- 6.2 Numerical Solution -- 6.3 2D and Oblique Modes: Squire Transformations -- 6.4 Shear and Diffusion Scalings -- 6.5 Application: Instabilities of a Stably Stratified Shear Layer -- 6.6 Application: Analysis of Observational Data -- 6.7 Summary -- 6.8 Further Reading -- 7 Nonparallel Flow: Instabilities of a Cylindrical Vortex -- 7.1 Cyclostrophic Equilibrium -- 7.2 The Perturbation Equations -- 7.3 Barotropic Modes (m = 0) -- 7.4 Axisymmetric Modes (l = 0) -- 7.5 Analytical Example: the Rankine Vortex -- 7.6 Numerical Example: a Continuous Vortex -- 7.7 Wave Interactions in Barotropic Vortices -- 7.8 Mechanisms of Centrifugal and Convective Instabilities -- 7.9 Swirling Flows -- 7.10 Summary -- 7.11 Further Reading -- 8 Instability in a Rotating Environment -- 8.1 Frontal Zones -- 8.2 Geostrophic Equilibrium and the Thermal Wind Balance -- 8.3 The Perturbation Equations -- 8.4 Energetics -- 8.5 The Vertical Vorticity Equation -- 8.6 Analytical Solution #1: Inertial and Symmetric Instabilities -- 8.7 Analytical Solution #2: Baroclinic Instability -- 8.8 Numerical Solution Method -- 8.9 Instability in the Ageostrophic Regime -- 8.10 Summary -- 8.11 Further Reading -- 9 Convective Instability in Complex Fluids -- 9.1 Conditional Instability in a Moist Atmosphere or a Freezing Ocean. , 9.2 Double Diffusive Instabilities -- 9.3 Bioconvection -- 9.4 CO[sub(2)] Sequestration -- 10 Summary -- 10.1 Equilibrium States -- 10.2 Instabilities -- Part II The View Ahead -- 11 Beyond Normal Modes -- 11.1 Instability as an Initial Value Problem -- 11.2 Transient Growth in Simple Linear Systems -- 11.3 Computing the Optimal Initial Condition -- 11.4 Optimizing Growth at t = 0[sup(+)] -- 11.5 Growth at Short and Long Times: a Simple Example -- 11.6 Example: The Piecewise Shear Layer -- 11.7 Mechanics of Transient Growth in a Shear Layer -- 11.8 Generalizing the Inner Product -- 11.9 Summary -- 11.10 Appendix: Singular Value Decomposition -- 11.11 Further Reading -- 12 Instability and Turbulence -- 12.1 Secondary Instabilities and the Transition to Turbulence -- 12.2 Turbulence-Driven Instabilities -- 12.3 Cyclic Instability -- 12.4 Further Reading -- 13 Refining the Numerical Methods -- 13.1 Higher-Order Finite Differences -- 13.2 Finite Differences on an Adaptive Grid -- 13.3 Galerkin Methods -- 13.4 The Shooting Method -- 13.5 Generalizations -- 13.6 Further Reading -- Appendix A Homework Exercises -- Appendix B Projects -- References -- Index. , English

Additional Edition: ISBN 1-108-70301-1

Language: English

Subjects: Geography

URL: Volltext  (kostenfrei)

URL: Inhaltstext

URL: https://www.cambridge.org/de/academic/subjects/earth-and-environmental-science/oceanography-and-marine-science/instability-geophysical-flows?format=AR

URL: https://doi.org/10.1017/9781108640084

UID:

Format: 1 online resource (351 pages)

ISBN: 9783319238470

Series Statement: Public Health Ethics Analysis Ser. ; v.3

Note: Intro -- Disclaimer -- Preface -- Contents -- Contributors -- Section I: Introduction to Public Health Ethics -- Chapter 1: Public Health Ethics: Global Cases, Practice, and Context -- 1.1 Introduction -- 1.2 Public Health -- 1.2.1 Core Values -- 1.2.2 Health Equity, Social Justice, and Social Determinants of Health -- 1.3 Ethics -- 1.3.1 Scientific Facts and Ethical Values -- 1.3.2 Ethics and Morality -- 1.3.3 Ethical Principles -- 1.3.4 Ethical Theories -- 1.3.5 Law Versus Ethics -- 1.4 Public Health Ethics -- 1.4.1 Research Ethics, Clinical Ethics, and Bioethics: Principlism and the Four Principles -- 1.4.2 Contrast between Clinical Ethics and Public Health Ethics -- 1.4.3 Individual Versus Relational Autonomy -- 1.4.4 Personal Autonomy as a Presumptive Value of Liberal Democracy -- 1.5 Ethical Frameworks -- 1.6 A Three-Step Approach to Public Health Decision Making -- 1.6.1 An Approach to Ethical Analysis and Justification in Context -- References -- Chapter 2: Essential Cases in the Development of Public Health Ethics -- 2.1 Introduction -- 2.2 Case Study: Jacobson v. Massachusetts -- 2.2.1 Background -- 2.2.2 Case Description -- 2.2.3 Discussion -- 2.3 Case Study: U.S. Public Health Service Research on Sexually Transmitted Disease: Alabama and Guatemala -- 2.3.1 Background -- 2.3.2 Case Description -- 2.3.3 Discussion -- 2.4 Case Study: The New York City A1C Registry -- 2.4.1 Background -- 2.4.2 Case Description -- 2.4.3 Discussion -- 2.5 Conclusions and Implications -- References -- Section II: Topics in Public Health Ethics -- Chapter 3: Resource Allocation and Priority Setting -- 3.1 Resource Allocation in Public Health -- 3.2 Collective Lessons from the Cases -- 3.3 Specific Ethical Issues in Resource Allocation -- 3.4 Decision-Making Process -- References -- 3.5 Case 1: Priority Setting and Crisis of Public Hospitals in Colombia. , 3.5.1 Background -- 3.5.2 Case Description -- 3.5.3 Discussion Questions -- References -- 3.6 Case 2: Intersection of Public Health and Mental Health: Meeting Family Needs -- 3.6.1 Background -- 3.6.2 Case Description -- 3.6.3 Discussion Questions -- References -- 3.7 Case 3: Public-Private Partnerships: Role of Corporate Sponsorship in Public Health -- 3.7.1 Background -- 3.7.2 Case Description -- 3.7.3 Discussion Questions -- References -- 3.8 Case 4: Black-White Infant Mortality: Disparities, Priorities, and Social Justice -- 3.8.1 Background -- 3.8.2 Case Description -- 3.8.3 Discussion Questions -- References -- 3.9 Case 5: Priority Setting in Health Care: Ethical Issues -- 3.9.1 Background -- 3.9.2 Case Description -- 3.9.3 Discussion Questions -- References -- 3.10 Case 6: Critical Care Triage in Pandemics -- 3.10.1 Background -- 3.10.2 Case Description -- 3.10.3 Discussion Questions -- References -- Chapter 4: Disease Prevention and Control -- 4.1 Introduction -- 4.2 Mandatory Treatment and Vaccination -- 4.3 Disease Screening and Surveillance -- 4.4 Stigma -- 4.5 Access to Care -- 4.6 Health Promotion Incentives -- 4.7 Emergency Response -- 4.8 Conclusion -- References -- 4.9 Case 1: Mandatory Vaccination in Measles Outbreaks -- 4.9.1 Background -- 4.9.2 Case Description -- 4.9.3 Discussion Questions -- References -- 4.10 Case 2: Public Health Approaches to Preventing Mother-to-Child HIV Transmission -- 4.10.1 Background -- 4.10.2 Case Description -- 4.10.3 Discussion Questions -- References -- 4.11 Case 3: Newborn Bloodspot Screening: Personal Choice or Public Health Necessity? Storage and Ownership of Newborn Bloodspots -- 4.11.1 Background -- 4.11.2 Case Description -- 4.11.3 Discussion Questions -- References -- 4.12 Case 4: Decoding Public Health Ethics and Inequity in India: A Conditional Cash Incentive Scheme-Janani Suraksha Yojana. , 4.12.1 Background -- 4.12.2 Case Description -- 4.12.3 Discussion Questions -- References -- 4.13 Case 5: HIV Criminalization and STD Prevention and Control -- 4.13.1 Background -- 4.13.2 Case Description -- 4.13.3 Discussion Questions -- References -- 4.14 Case 6: Ethics of Administering Anthrax Vaccine to Children -- 4.14.1 Background -- 4.14.2 Case Description -- 4.14.3 Discussion Questions -- References -- 4.15 Case 7: Non-adherence to Treatment in Patients with Tuberculosis: A Challenge for Minimalist Ethics -- 4.15.1 Background -- 4.15.2 Case Description -- 4.15.3 Discussion Questions -- References -- 4.16 Case 8: Mass Evacuation -- 4.16.1 Background -- 4.16.2 Case Description -- 4.16.3 Discussion Questions -- References -- Chapter 5: Chronic Disease Prevention and Health Promotion -- 5.1 Introduction -- 5.2 Individuals -- 5.3 Formal and Informal Health Workers -- 5.4 Governments (At Different Levels) -- 5.5 Corporate Entities -- 5.6 Case Studies -- References -- 5.7 Case 1: Municipal Action on Food and Beverage Marketing to Youth -- 5.7.1 Background -- 5.7.2 Case Description -- 5.7.3 Discussion Questions -- References -- 5.8 Case 2: Obesity Prevention in Children: Media Campaigns, Stigma, and Ethics -- 5.8.1 Background -- 5.8.2 Case Description -- 5.8.3 Discussion Questions -- References -- 5.9 Case 3: Obesity Stigma in Vulnerable and Marginalized Groups -- 5.9.1 Background -- 5.9.2 Case Description -- 5.9.3 Discussion Questions -- References -- 5.10 Case 4: Water Fluoridation: The Example of Greece -- 5.10.1 Background -- 5.10.2 Case Description -- 5.10.3 Discussion Questions -- References -- 5.11 Case 5: The Prohibition of Smoking in Public Places in Bulgaria -- 5.11.1 Background -- 5.11.2 Case Description -- 5.11.3 Discussion Questions -- References -- Chapter 6: Environmental and Occupational Public Health. , 6.1 Environment and Workplace: Key Venues for Public Health -- 6.2 Population Benefits, Individual Rights, and Ethically Acceptable Risk -- 6.3 Systems and Power: The Ethical Importance of Ecological and Social Context -- References -- 6.4 Case 1: Assessing Mining's Impact on Health Equity in Mongolia -- 6.4.1 Background -- 6.4.2 Case Description -- 6.4.3 Discussion Questions -- References -- 6.5 Case 2: Exceptions to National MRSA Prevention Policy for a Medical Resident with Untreatable MRSA Colonization -- 6.5.1 Background -- 6.5.2 Case Description -- 6.5.3 Discussion Questions -- References -- 6.6 Case 3: Safe Water Standards and Monitoring of a Well Construction Program -- 6.6.1 Background -- 6.6.2 Case Description -- 6.6.3 Discussion Questions -- References -- 6.7 Case 4: Implementation of Global Public Health Programs and Threats to Personal Safety -- 6.7.1 Background -- 6.7.2 Case Description -- 6.7.3 Discussion Questions -- References -- Chapter 7: Vulnerability and Marginalized Populations -- 7.1 Introduction -- 7.2 Different Approaches to the Concept of Vulnerability -- 7.3 Concerns Surrounding Approach (V2): Universal Condition -- 7.4 Concerns Surrounding Approach (V3): Specific Attributes, Contexts, or Groups -- 7.5 Concerns Surrounding Approach (V4): Overarching Concepts -- 7.6 Simplifying the Concept of Vulnerability (V5): The Moral-Marker Approach -- References -- 7.7 Case 1: Reducing Sudden Infant Death Syndrome in a Culturally Diverse Society: The New Zealand Cot Death Study and National Cot Death Prevention Programme -- 7.7.1 Background -- 7.7.2 Case Description -- 7.7.3 Discussion Questions -- References -- 7.8 Case 2: Medical Tourism and Surrogate Pregnancy: A Case of Ethical Incoherence -- 7.8.1 Background -- 7.8.2 Case Description -- 7.8.3 Discussion Questions -- References. , 7.9 Case 3: Compulsory Treatment for Injection Drug Use after Incarceration -- 7.9.1 Background -- 7.9.2 Case Description -- 7.9.3 Discussion Questions -- References -- 7.10 Case 4: Unanticipated Vulnerability: Marginalizing the Least Visible in Pandemic Planning -- 7.10.1 Background -- 7.10.2 Case Description -- 7.10.3 Discussion Questions -- References -- 7.11 Case 5: Can Asylum Seeking Be Managed Ethically? -- 7.11.1 Background -- 7.11.2 Case Description -- 7.11.3 Discussion Questions -- References -- 7.12 Case 6: Tuberculosis Screening, Testing, and Treatment among Asylum Seekers -- 7.12.1 Background -- 7.12.2 Case Description -- 7.12.3 Discussion Questions -- References -- Chapter 8: International Collaboration for Global Public Health -- 8.1 Introduction -- 8.2 The Rise of Globalization and Global Health -- 8.2.1 Collective Health -- 8.2.2 Coordination -- 8.2.3 Accountability -- 8.3 Ethics Frameworks for Global Health -- 8.3.1 Principles and Benchmarks -- 8.3.2 Human Rights -- 8.3.3 Social Determinants of Health -- 8.4 Summary -- References -- 8.5 Case 1: The Ethics of HIV Testing Policies -- 8.5.1 Background -- 8.5.2 Case Description -- 8.5.3 Discussion Questions -- References -- 8.6 Case 2: Just Allocation of Pre-exposure Prophylaxis Drugs in Sub-Saharan Africa -- 8.6.1 Background -- 8.6.2 Case Description -- 8.6.3 Discussion Questions -- References -- 8.7 Case 3: Drug Trials in Developing Countries -- 8.7.1 Background -- 8.7.2 Case Description -- 8.7.3 Discussion Questions -- References -- 8.8 Case 4: Ethical Issues in Responding to International Medication Stock-Outs -- 8.8.1 Background -- 8.8.2 Case Description -- 8.8.3 Discussion Questions -- References -- 8.9 Case 5: Transmitting Cholera to Haiti -- 8.9.1 Background -- 8.9.2 Case Description -- 8.9.3 Discussion Questions -- References. , 8.10 Case 6: Perilous Path to Middle East Peace: The Sanctions Dilemma.

Additional Edition: Print version: H. Barrett, Drue Public Health Ethics: Cases Spanning the Globe Cham : Springer International Publishing AG,c2016 ISBN 9783319238463

Language: English

Keywords: Electronic books. ; Electronic books. ; Electronic books.

URL: Click to View

URL: Click here to view book

URL: FULL  ((Currently Only Available on Campus))

URL: lizenzpflichtig

UID:

Format: 1 online resource (332 pages)

Edition: 1st ed.

ISBN: 1-78756-189-5 , 1-78756-187-9

Series Statement: Corporate ethics for turbulent markets

Content: The tapestry of human behaviour in the marketplace today is turbulent, unpredictable, and chaotic. Yet it is also so diverse, rich and global that it presents a rare ethical and moral opportunity, and challenge, to out-behave competition and create enduring value. This is corporate ethics for corporate advantage. Corporate Ethics for Turbulent Markets: The Market Context of Executive Decisions focuses on the HOW of doing business the economic, social, ethical, moral and spiritual values we bring to our business ventures - and how thereby we impact the world. The book focuses on the LEMS (legality, ethicality, morality, and spirituality) technique that we submit as a prescriptive benchmarking tool for all corporate thinking, deliberation, explanation, evaluation, choices, strategic implementation, accountability and moral responsibility. It demonstrates that by going beyond the legal obligation (legality) to do the "right thing" (ethicality), to do the "right thing rightly" (morality), and doing the "right thing rightly and for the right intentions" (spirituality), we can create a sure strategy for good decision making and implementation that can heal the world from its current addictions to corporate fraud in all its evil forms. Envisioning a moral reawakening, this book will challenge business students and executives alike to re-evaluate the moral justification of business choices, decisions, actions and their consequences. LEMS as a four-dimensional cross-checking skill for all that we think, do, become and be takes time and patience but it can surely heal an otherwise divided and broken world.

Note: Cover -- Title Page -- Copyright Page -- Acknowledgements -- Contents -- About the Author -- Prologue: Corporate Ethics for Turbulent Markets of Today -- Corporate Statesmen -- Critical Importance of Corporate Ethics Today -- Corporate Ethics through Real Current Business Cases -- The Structure of This Book -- The Target Audience -- The Uniqueness of This Book -- Notes -- Chapter 1 Characterizing Market Turbulence Today as a Source of Market Opportunity -- Executive Summary -- 1.1. Introduction -- 1.2. What Is Market Turbulence? -- 1.3. Tracking the Emergence of Economies, Their Market Turbulence, and Opportunity -- 1.4. Current Market Turbulence and Economic Chaos -- 1.5. Recent Major Factors that Generated Market Turbulence -- 1.5.1. Chinese Invasion of Global Markets -- 1.5.2. Global Climate Change and Policies -- 1.5.3. Brexit and Global Market Turbulence -- 1.5.4. Immigrant Populations and Global Refugee Crisis -- 1.5.5. Artificial Intelligence and Market Turbulence -- 1.6. Demonetization in India and Market Turbulence -- 1.6.1. Structure of Market Turbulence -- 1.6.2. Relevance of Corporate Ethics Under Market Turbulence Today -- 1.6.3. Market Turbulence as Market Certainty, Risk, Uncertainty, and Chaos -- 1.7. Market Turbulence as Buyer-Seller Information Asymmetry -- 1.7.1. Nature of Buyer-Seller Information Asymmetry -- 1.8. Concluding Remarks: Managerial Implications -- Notes -- Chapter 2 The Domain and Context of Corporate Ethics: Introducing Concepts and Directions -- Executive Summary -- 2.1. Introduction -- 2.2. Toward a Strong Positive Approach to Corporate Ethics -- 2.3. Conceptual versus Operational Definitions -- 2.4. What Is Spirituality? -- 2.5. What Is Morality? -- 2.6. What Is Ethicality? -- 2.7. What Is Legality? -- 2.8. What Are Values? -- 2.9. Business Ethics and Managerial Ethics -- 2.10. What Is Corporate Ethics?. , 2.11. Commonality Between Ethics, Business Ethics, and Corporate Ethics -- 2.12. Descriptive versus Prescriptive Ethics -- 2.13. Major Ethical Theories -- 2.14. The Ethical Theory of Teleology -- 2.15. The Ethical Theory of Deontology -- 2.16. The Ethical Theory of Distributive Justice -- 2.17. The Ethical Theory of Corrective Justice -- 2.18. Corporate Value Ethics -- 2.19. The Gray Area in Corporate Ethics -- 2.20. Methodology of Corporate Ethics -- 2.21. Legal, Ethical, Moral, and Spiritual Executive Conduct -- 2.22. The Dynamics of Corporate Ethics -- 2.23. Concluding Remarks -- Notes -- Chapter 3 A Systems Thinking Approach to Understand the Challenge of Corporate Ethics in the Turbulent Markets of Today -- Executive Summary -- 3.1. Introduction -- 3.2. What Is a System? -- 3.3. What Is Systems Thinking? -- 3.4. Market Turbulence Problem as a System at Unrest -- 3.5. Systems Thinking and Process Mapping -- 3.6. The Concept of Feedback -- 3.7. The Reinforcing and Balancing Feedback Processes -- 3.8. Free Enterprise Capitalism System -- 3.9. FECS as a System of Subjects, Objects, Properties, and Events -- 3.10. Critical Systems Thinking Questions for Corporate Ethics -- 3.10.1. Systemic Laws for Systems Thinking -- 3.10.1.1. Law 1: Today's Problems Come from Yesterday's Solutions -- 3.10.1.2. Law 2: The Harder You Push, the Harder the System Pushes Back -- 3.10.1.3. Law 3: Behavior Grows Better Before It Grows Worse -- 3.10.1.4. Law 4: The Easy Way Out Usually Leads Back In -- 3.10.1.5. Law 5: The Cure Can Be Worse than the Disease -- 3.10.1.6. Law 6: Faster Is Slower -- 3.10.1.7. Law 7: Cause and Effect Are Not Closely Related in Time or Space -- 3.10.1.8. Law 8: Small Changes Can Produce Big Results - but the Areas of Higher Leverage Are Often the Least Obvious -- 3.10.1.9. Law 9: You Can Have Your Cake and Eat It too - but Not All at Once. , 3.10.1.10. Law 10: Dividing an Elephant in Half Does Not Produce Two Elephants -- 3.10.1.11. Law 11: There Is No Blame -- 3.10.2. Archetypes of Systems Thinking: Nature's Templates That Control Human Events -- 3.10.2.1. Archetype 1: Limits to Growth -- 3.10.2.2. Archetype 2: Shifting the Burden -- 3.10.2.3. Archetype 3: "Fixes That Backfire" -- 3.10.2.4. Archetype 4: "Tragedy of the Commons" -- 3.10.2.5. Archetype 5: "Accidental Adversaries" -- 3.10.2.6. Archetype 6: "Success to the Successful" -- 3.10.2.7. Archetype 7: "Balancing Process with Delay" -- 3.10.2.8. Archetype 8: "Growth and Underinvestment" -- 3.10.2.9. Archetype 9: "Escalation" -- 3.10.2.10. Archetype 10: "Eroding Goals" -- 3.11. Concluding Remarks -- Notes -- Chapter 4 The Success of Free Enterprise Capitalist System When Designed and Deployed Rightly -- Executive Summary -- 4.1. Introduction -- Notes -- References -- 4.2. In Defense of Capitalism -- 4.3. What Is Capitalism? -- 4.4. Morality of Private Property -- 4.5. Hobbesian Capitalism -- 4.6. Adam Smith's Version of Capitalism -- 4.7. In Defense of Free Enterprise Capitalist System -- 4.8. Morality of Profits and Losses -- 4.9. Max Weber's Ethics of Capitalism -- 4.10. Welfare Capitalism or the Dependence Culture -- 4.11. Moral Issues on Welfare Capitalism Based on Taxing the Rich -- 4.12. Systems Thinking: New Ways of Understanding Free Enterprise Capitalist System -- 4.13. A Systems View for Resolving Capitalist Problems -- 4.14. New Ways of Understanding Capitalism -- 4.15. Inclusive Capitalism -- 4.16. Inclusive Capitalism and Intentional Public Policies -- 4.17. Conscious Capitalism -- 4.18. The Dharma of Capitalism -- 4.19. Concluding Remarks -- Chapter 5 The Destruction of Free Enterprise Capitalist System When Infected by Fraud, Corruption, and Bribery -- Executive Summary -- 5.1. Introduction. , 5.2. Corporate Fraud and Corporate Damages -- 5.3. Contemporary Versions of Fraud, Corruption, and Bribery -- 5.4. Investigating Fraud, Corruption, and Bribery -- 5.4.1 Seduction -- 5.5. Types of Corporate Fraud -- 5.6. Basic Instruments of Market Turbulence as Corporate Frauds -- 5.7. Market Turbulence of Capitalism as Boundary Thinking -- 5.8. The Inherent Social Contradictions of Capitalism -- 5.9. Other Social Externalities of Capitalism -- 5.10. What Can Turbulent Markets Do to Combat Fraud? -- 5.11. Fraud is Failure of Corporate Accountability -- 5.12. How Do We Combat Corporate Fraud? -- 5.13. Why Does Corporate Failure in Ethics Occur? -- 5.14. Reduce Fraud by Reducing Legal and Occupational Ambiguity -- 5.15. Concluding Remarks -- Notes -- Chapter 6 The Turbulent Market of Modern Debt-overleveraged and Promoter-dominated Corporations -- Executive Summary -- References -- References -- References -- 6.1. Ethics of Promoter Dominance in Modern Corporations -- 6.2. The Morality of Promoter Dominance -- 6.3. The Morality of Tax Subsidy and Debt Distortion -- 6.3.1. Advantages of Debt -- 6.3.2. Disadvantages of Debt -- 6.4. A New Breed of Hybrid Financial Instruments -- 6.5. Understanding Debt from Multiple Viewpoints -- 6.6. Ethics of Financing Decisions such as EBITDA -- 6.7. Bankruptcy and Credit -- 6.7.1. Bankruptcy assumes credit -- 6.8. Concluding Remarks -- 6.9. Ethical and Moral Concerns -- Notes -- Chapter 7 Artificial Intelligence and the Emergent Turbulent Markets: New Challenges to Corporate Ethics Today -- Executive Summary -- 7.1. Introduction -- 7.1.1. What Is AI? -- 7.1.2. The Fundamental Essence and Operations of AI -- 7.1.3. A Timeline of Major Advancements in AI -- 7.1.4. Current Wanton AI Developments -- 7.1.5. Advantages of AI -- 7.1.6. Disadvantages of AI -- 7.1.7. AI Will Not Automate All Jobs. , 7.1.8. The Great Potential of AI -- 7.2. The LEMS Challenge of AI to Corporate Ethics -- 7.2.1. Legal Aspects of AI -- 7.2.2. Ethical Challenges of AI -- 7.2.3. Moral Challenges of AI -- 7.2.4. Spiritual Challenges of AI -- 7.2.5. AI Contributes to Better Life -- 7.3. Concluding Remarks -- Notes -- Chapter 8 The Ethics of Reinventing the Morally Embattled Corporation -- Executive Summary -- 8.1. Introduction -- 8.2. Imperfections in the FECS-based Corporation -- 8.3. Growing Dissatisfaction with Corporations -- 8.4. Promoter Dominance Paralyzes the Corporation -- 8.5. Share Buyback for Restoring Corporate Control -- 8.6. High-potential Dynamic Startups -- 8.7. Crowd-funding and Crowd Innovations Challenge the Corporation -- 8.8. Is the Corporation an Over-taxed Endangered Species Today? -- 8.9. Chinese Economic Invasion Threatens American Capitalism and the Corporation -- 8.10. Reinventing the Capitalist Corporation -- 8.10.1. Reinventing the Corporation -- 8.10.1.1. Fluidity of Asset Management -- 8.10.1.2. Change in Ownership -- 8.10.1.3. Long-termism and NPDD -- 8.10.1.4. Comprehensive and Collaborative Entrepreneurship, Social Entrepreneurship, and Startups -- 8.10.1.5. Corporate Governance -- 8.10.1.6. Democratization of Capital -- 8.11. Concluding Challenge -- 8.12. Ethical Questions: -- Notes -- Epilogue: The Twenty-first Century Legal, Ethical, Moral, and Spiritual (LEMS) Challenges of Corporate Governance -- Executive Summary -- Corporate Value Ethics -- Organizational Morality as Systems Thinking -- Systems Thinking for Understanding Market Turbulence -- Capitalism and Economic Freedom -- Ethics of Free Enterprise Competition: The Golden Rule -- Market Turbulence and Market Disruption -- Concluding Remarks -- Notes -- References -- Further Reading -- Author Index -- Case Index -- Subject Index.

Additional Edition: ISBN 1-78756-190-9

Additional Edition: ISBN 1-78756-188-7

Language: English

Subjects: Economics

Keywords: Electronic books.

URL: Volltext  (URL des Erstveröffentlichers)

URL: Click to View

URL: https://www.emerald.com/insight/publication/doi/10.1108/9781787561878

UID:

Format: xiv, 546 Seiten : , Diagramme ; , 254 mm.

Edition: Second edition

ISBN: 978-1-4625-4986-3

Series Statement: Methodology in the Social Sciences

Content: The most user-friendly and authoritative resource on missing data has been completely revised to make room for the latest developments that make handling missing data more effective. The second edition includes new methods based on factored regressions, newer model-based imputation strategies, and innovations in Bayesian analysis. State-of-the-art technical literature on missing data is translated into accessible guidelines for applied researchers and graduate students. The second edition takes an even, three-pronged approach to maximum likelihood estimation (MLE), Bayesian estimation as an alternative to MLE, and multiple imputation. Consistently organized chapters explain the rationale and procedural details for each technique and illustrate the analyses with engaging worked-through examples on such topics as young adult smoking, employee turnover, and chronic pain. The companion website (www.appliedmissingdata.com) includes datasets and analysis examples from the book, up-to-date software information, and other resources.New to This Edition*Expanded coverage of Bayesian estimation, including a new chapter on incomplete categorical variables.*New chapters on factored regressions, model-based imputation strategies, multilevel missing data-handling methods, missing not at random analyses, and other timely topics.*Presents cutting-edge methods developed since the 2010 first edition; includes dozens of new data analysis examples.*Most of the book is entirely new.

Note: References S. 493-517, Author Index S. 519-528, Subject Index S. 529-545 , 1. Introduction to Missing Data; 1.1 Chapter Overview; 1.2 Missing Data Patterns; 1.3 Missing Data Mechanisms; 1.4 Diagnosing Missing Data Mechanisms; 1.5 Auxiliary Variables; 1.6 Analysis Example: Preparing for Missing Data Handling; 1.7 Older Missing Data Methods; 1.8 Comparing Missing Data Methods via Simulation; 1.9 Planned Missing Data; 1.10 Power Analyses for Planned Missingness Designs; 1.11 Summary and Recommended Readings; 2.- , Maximum Likelihood Estimation; 2.1 Chapter Overview; 2.2 Probability Distributions versus Likelihood Functions; 2.3 The Univariate Normal Distribution; 2.4 Estimating Unknown Parameters; 2.5 Getting an Analytic Solution; 2.6 Estimating Standard Errors; 2.7 Information Matrix and Parameter Covariance Matrix; 2.8 Alternative Approaches to Estimating Standard Errors; 2.9 Iterative Optimization Algorithms; 2.10 Linear Regression; 2.11 Significance Tests; 2.12 Multivariate Normal Data; 2.13 Categorical Outcomes: Logistic and Probit Regression; 2.14 Summary and Recommended Readings; 3.- , Maximum Likelihood Estimation with Missing Data; 3.1 Chapter Overview; 3.2 The Multivariate Normal Distribution Revisited; 3.3 How Do Incomplete Data Records Help?; 3.4 Standard Errors with Incomplete Data; 3.5 The Expectation Maximization Algorithm; 3.6 Linear Regression; 3.7 Significance Testing; 3.8 Interaction Effects; 3.9 Curvilinear Effects; 3.10 Auxiliary Variables; 3.11 Categorical Outcomes; 3.12 Summary and Recommended Readings; 4. Bayesian Estimation; 4.1 Chapter Overview; 4.2 What Makes Bayesian Statistics Different?; 4.3 Conceptual Overview of Bayesian Estimation; 4.4 Bayes’ Theorem; 4.5 The Univariate Normal Distribution; 4.6 MCMC Estimation with the Gibbs Sampler; 4.7 Estimating the Mean and Variance with MCMC; 4.8 Linear Regression; 4.9 Assessing Convergence of the Gibbs Sampler; 4.10 Multivariate Normal Data; 4.11 Summary and Recommended Readings; 5.- , Bayesian Estimation with Missing Data; 5.1 Chapter Overview; 5.2 Imputing an Incomplete Outcome Variable; 5.3 Linear Regression; 5.4 Interaction Effects; 5.5 Inspecting Imputations; 5.6 The Metropolis–Hastings Algorithm; 5.7 Curvilinear Effects; 5.8 Auxiliary Variables; 5.9 Multivariate Normal Data; 5.10 Summary and Recommended Readings; 6. Bayesian Estimation for Categorical Variables; 6.1 Chapter Overview; 6.2 Latent Response Formulation for Categorical Variables; 6.3 Regression with a Binary Outcome; 6.4 Regression with an Ordinal Outcome; 6.5 Binary and Ordinal Predictor Variables; 6.6 Latent Response Formulation for Nominal Variables; 6.7 Regression with a Nominal Outcome; 6.8 Nominal Predictor Variables; 6.9 Logistic Regression; 6.10 Summary and Recommended Readings; 7.- , Multiple Imputation; 7.1 Chapter Overview; 7.2 Agnostic versus Model-Based Multiple Imputation; 7.3 Joint Model Imputation; 7.4 Fully Conditional Specification; 7.5 Analyzing Multiply-Imputed Data Sets; 7.6 Pooling Parameter Estimates; 7.7 Pooling Standard Errors; 7.8 Test Statistic and Confidence Intervals; 7.9 When Might Multiple Imputation Give Different Answers?; 7.10 Interaction and Curvilinear Effects Revisited; 7.11 Model-Based Imputation; 7.12 Multivariate Significance Tests; 7.13 Summary and Recommended Readings; 8. Multilevel Missing Data; 8.1 Chapter Overview; 8.2 Random Intercept Regression Models; 8.3 Random Coefficient Models; 8.4 Multilevel Interaction Effects; 8.5 Three-Level Models; 8.6 Multiple Imputation; 8.7 Joint Model Imputation; 8.8 Fully Conditional Specification Imputation; 8.9 Maximum Likelihood Estimation; 8.10 Summary and Recommended Readings; 9.- , Missing Not at Random Processes; 9.1 Chapter Overview; 9.2 Missing Not at Random Processes Revisited; 9.3 Major Modeling Frameworks; 9.4 Selection Models for Multiple Regression; 9.5 Model Comparisons and Individual Influence Diagnostics; 9.6 Selection Model Analysis Examples; 9.7 Pattern Mixture Models for Multiple Regression; 9.8 Pattern Mixture Model Analysis Examples; 9.9 Longitudinal Data Analyses; 9.10 Diggle–Kenward Selection Model; 9.11 Shared Parameter (Random Coefficient) Selection Model; 9.12 Random Coefficient Pattern Mixture Models; 9.13 Longitudinal Data Analysis Examples; 9.14 Summary and Recommended Readings; 10.- , Special Topics and Applications; 10.1 Chapter Overview; 10.2 Descriptive Summaries, Correlations, and Subgroups; 10.3 Non-Normal Predictor Variables; 10.4 Non-Normal Outcome Variables; 10.5 Mediation and Indirect Effects; 10.6 Structural Equation Models; 10.7 Scale Scores and Missing Questionnaire Items; 10.8 Interactions with Scales; 10.9 Longitudinal Data Analyses; 10.10 Regression with a Count Outcome; 10.11 Power Analyses for Growth Models with Missing Data; 10.12 Summary and Recommended Readings; 11. Wrap-Up; 11.1 Chapter Overview; 11.2 Choosing a Missing Data-Handling Procedure; 11.3 Software Landscape; 11.4 Reporting Results from a Missing Data Analysis; 11.5 Final Thoughts and Recommended Readings; Appendix. Data Set Descriptions; Author Index; Subject Index; About the Author;

Language: English

Subjects: Psychology , Sociology

Keywords: Sozialwissenschaften ; Statistik ; Methodologie ; Fehlende Daten ; Datenauswertung

URL: Inhaltsverzeichnis

UID:

Format: 1 online resource (xix, 923 pages) : , illustrations

ISBN: 0-323-97219-5 , 9780323972192 , 0323972195

Content: "Advanced and Modern Approaches for Drug Delivery explores novel approaches currently used for drug delivery, including the must up-to-date techniques and technology. The approaches discussed allow pharmaceutical scientists to design effective drug delivery systems or devices for the management and treatment of numerous diseases and conditions. Detailed information on a wide variety of subjects, including dendrimers, lipid nanostructures, solid lipid nanoparticles, stimuli-responsive smart systems, self-assembled protein-drug nanoparticles, nanoconjugate formulations, nanofibers, iontophoretic systems, microneedle systems, ultra-sound triggered systems, targeted carrier-based intracellular delivery systems, resealed erythrocyte-based systems, 3 D-printing tool, site-specific monoclonal antibodies, and bio-inspired systems are all comprehensively discussed." --Provided by publisher

Note: Front Cover -- Advanced and Modern Approaches for Drug Delivery -- Advanced and Modern Approaches for Drug Delivery -- Copyright -- Contents -- Contributors -- 1 - Novel drug delivery system -- 1. Introduction -- 1.1 Advantages of NDDS -- 2. Novel drug delivery system -- 2.1 Liposomes -- 2.1.1 Composition of liposomes -- 2.1.2 Classification of liposomes -- 2.1.3 Advance and a recent update on the liposomes -- 2.1.3.1 Conventional liposomes comprising a phospholipid -- 2.1.3.2 PEGylated/stealth liposomes -- 2.1.3.3 Ligand-targeted liposomes -- 2.1.3.4 Multifunctional liposomes -- 2.1.4 Liposomes-based marketed products -- 2.2 Transfersomes -- 2.2.1 Merit/demerit of transferesomes -- 2.3 Ethosomes -- 2.3.1 Advantages of ethosomes -- 2.4 Nanoparticles -- 2.4.1 Advantages of nanoparticles -- 2.5 Microspheres -- 2.5.1 Advantages of microspheres -- 2.6 Phytosomes -- 2.6.1 Advantages of phytosomes -- 2.7 Solid lipid nanoparticles -- 2.7.1 Advantage of SLNs -- 2.8 Niosomes -- 2.8.1 Advantages of niosomes -- 2.9 Proniosomes -- 2.9.1 Advantages of proniosomes -- 2.10 Liquid crystals -- 2.10.1 Advantages of liquid crystals -- 2.11 Dendrimer -- 2.11.1 Advantages of dendrimers -- 2.12 Hydrogels -- 2.12.1 Advantages of hydrogels -- 3. Conclusion -- References -- Further reading -- 2 - Self-emulsifying systems for drug delivery: advances and challenges -- 1. Introduction -- 2. Construction of pseudoternary phase diagrams -- 3. Self-emulsifying systems for oral drug delivery -- 3.1 General components of SEDDSs for oral drug delivery -- 3.2 Applications of SEDDSs for oral drug delivery -- 3.2.1 Liquid SEDDSs for oral drug delivery -- 3.2.2 Solid SEDDSs (S-SEDDSs) for oral drug delivery -- 3.2.3 Supersaturable SEDDSs for oral drug delivery -- 4. Self-emulsifying ocular drug delivery systems -- 5. Self-emulsifying dermal and transdermal drug delivery systems. , 5.1 Transdermal drug delivery -- 5.2 Targeted delivery to skin strata -- 6. Self-emulsifying vaginal drug delivery systems -- 7. Self-emulsifying rectal drug delivery systems -- 8. Self-emulsifying parenteral drug delivery systems -- 9. Concluding remarks -- References -- 3 - Gastroretentive drug delivery approaches: concepts, approaches, and applications -- 1. Introduction -- 2. Gastroretentive drug delivery systems -- 3. Anatomy and physiology of the stomach -- 4. Factors affecting gastric retention ability of a delivery system -- 5. Approaches to developing GRDDS -- 5.1 Mucoadhesive systems -- 5.2 High-density systems -- 5.3 Floating systems -- 6. Swellable and expandable systems -- 7. Magnetic systems -- 8. Application of gastroretentive dosage forms -- 9. Conclusion -- References -- 4 - Current advancements in nasopulmonary drug delivery systems -- 1. Introduction -- 2. Anatomy and physiology of the respiratory system -- 3. Advantages and limitations of the nasopulmonary route -- 3.1 Mucociliary clearance -- 3.2 Alveolar macrophages -- 3.3 Enzymatic degradation -- 3.4 Rapid systemic absorption -- 4. Factors determining pulmonary drug distribution, effectiveness, and clearance -- 4.1 Particle size -- 4.2 Particle shape -- 4.3 Stealth ability -- 5. Materials selection for NPDDSSs -- 6. Applications of NPDDSs -- 7. Methods of targeting in NPDDSs -- 8. Next-generation impactor devices as lung simulators -- Acknowledgement -- References -- 5 - Osmotic drug deliverance systems: concepts, approaches, and applications -- 1. Introduction -- 2. Controlled drug deliverance by osmosis machineries -- 3. Concept of osmosis -- 4. Basic ingredients of osmotic machineries -- 4.1 Medication -- 4.2 Osmotic agent -- 4.3 Semipenetrable membrane -- 4.4 Substance for semipenetrable membrane -- 4.4.1 Cellulose acetate membrane -- 4.4.2 Compound polyamide membrane. , 4.4.3 Arbitrary feature of semipenetrable membrane -- 4.5 Hole forming factors -- 4.6 Covering solvent -- 4.7 Emulsifying agents -- 4.8 Flux moderating factors -- 4.9 Wicking factors -- 4.10 Barrier cortex formers -- 4.11 Plasticizers -- 5. Sorts of osmotically controlled drug deliverance devices -- 5.1 Oral osmotic drug deliverance devices -- 5.1.1 Single chamber osmotic pump -- 5.1.1.1 Elementary osmotic pump (EOP) -- 5.1.1.2 Controlled porosity of osmotic pump (COP) -- 5.1.1.3 Osmotic erupting osmotic pump -- 5.1.2 Multichamber osmotic pump -- 5.1.2.1 Push-pull osmotic pump -- 5.1.2.2 Osmotic pump with nonextending secondary section -- 5.1.2.3 Sandwich osmotic tablets (SOTS) -- 5.2 Implantable osmotic drug deliverance devices -- 5.2.1 Rose and nelson pump -- 5.2.2 Higuchi leeper pump -- 5.2.3 Higuchi theeuwes pump -- 5.2.4 Oral osmotic capsules -- 5.2.4.1 OROS-CT -- 5.2.4.2 Liquid oral release osmotic system (L-OROS) -- 5.2.4.3 Multiparticulate delayed release systems -- 5.2.4.4 Telescopic capsule for postponed diffusion -- 6. Conclusion -- References -- 6 - Nanogels as drug delivery platform -- 1. Introduction -- 2. Bibliometric analysis of the nanogels as drug delivery platform -- 3. Drug release -- 4. Nanogels as a drug delivery platform in different systems -- 5. Other applications -- 6. Global market report -- 7. Disadvantages of the use of nanogels as drug carriers -- 8. Conclusions -- References -- 7 - Nanoliposomes as safe and efficient drug delivery nanovesicles -- 1. Introduction -- 2. Nanoliposomes preparation -- 2.1 Chemical components -- 2.2 Methods of preparation -- 2.2.1 Thin-layer hydration -- 2.2.2 Reverse-phase evaporation -- 2.2.3 Solvent injection -- 2.2.4 Heating method -- 2.2.5 Freeze-drying method -- 2.2.6 Microfluidics channel -- 2.2.7 Supercritical fluids -- 3. Methods of drug loading -- 3.1 Passive loading techniques. , 3.2 Active loading techniques -- 3.2.1 pH gradient -- 3.2.2 Ammonium sulfate gradient -- 3.2.3 Metal-ion complexation gradient -- 4. Analysis and characterization of nanoliposomes -- 4.1 Particle size and morphology -- 4.2 Surface charge -- 4.3 Zeta potential -- 4.4 Polydispersity index -- 4.5 Encapsulation efficiency and loading capacity -- 4.6 Drug release -- 5. Types of nanoliposomes in drug delivery -- 5.1 Conventional nanoliposomes -- 5.2 PEGylated nanoliposomes -- 5.3 Coated nanoliposomes -- 5.4 Targeted nanoliposomes -- 5.5 Stimulus-responsive nanoliposomes -- 6. Stability and safety of nanoliposomes -- 7. Applications of nanoliposomes in treatment of human diseases -- 7.1 Treatment of cancer -- 7.1.1 Passive delivery -- 7.1.2 Targeted delivery -- 7.1.3 Stimulus responsive delivery -- 7.2 Treatment of neurological disorders -- 7.3 Treatment of liver diseases -- 8. Nanoliposomal vaccines -- 9. Nanoliposomal bioreactors -- 10. Nanoliposomes in theranostics -- 11. Marketed nanoliposomes and future challenges -- 12. Conclusions -- References -- 8 - Transferosomes: a novel nanotechnological approach for transdermal drug delivery -- 1. Introduction -- 2. Transferosomes -- 3. Advantages of transferosomes -- 4. Limitations of transferosomes -- 5. Composition of transferosomes -- 6. Mechanism of penetration of transferosomes across stratum corneum -- 7. Methods of transferosome preparation -- 7.1 Vortexing-sonication -- 7.2 Rotary film evaporation -- 7.3 Reverse-phase evaporation -- 7.4 Freeze-thaw method -- 7.5 Ethanol injection -- 7.6 Homogenization/extrusion -- 7.7 Protransferosome-transferosome method -- 7.8 Microfluidics method -- 8. Characterizations of transferosomes -- 8.1 Vesicle size and distribution -- 8.2 Zeta-potential -- 8.3 Drug entrapment efficiency -- 8.4 Surface topography -- 8.5 Number of vesicles per cubic mm -- 8.6 Drug content. , 8.7 Turbidity measurement -- 8.8 Measurement of degree of deformability or permeability -- 8.9 Penetration ability -- 8.10 Occlusion effects -- 8.11 Confocal scanning laser microscopy (CSLM) study -- 8.12 In vitro drug release evaluation -- 8.13 In vitro skin permeation study -- 9. Applications of transferosomes -- 9.1 Protein and peptide delivery -- 9.2 Corticosteroids -- 9.3 Anticancer drugs -- 9.4 Anaesthetics -- 9.5 Nonsteroidal anti-inflammatory drugs (NSAIDs) -- 9.6 Antipsycotic drugs -- 10. Conclusions -- References -- 9 - Niosomes as a promising nanovesicular drug delivery -- 1. Introduction -- 2. Composition of niosomes -- 2.1 Nonionic surfactants -- 2.2 Cholesterol -- 2.3 Charge inducer molecules -- 2.4 Hydration medium -- 3. Factors affecting niosomal formulation -- 3.1 Surfactant -- 3.2 Cholesterol -- 3.3 Drug -- 3.4 Hydration condition -- 3.5 Resistance to osmotic stress -- 3.6 Method of preparation -- 4. Types of niosomes -- 5. Fabrication methods of niosomes -- 5.1 Thin layer evaporation/handshaking -- 5.2 Reverse phase evaporation -- 5.3 Bubble -- 5.4 Ether injection -- 5.5 Sonication -- 5.6 Microfluidization -- 5.7 Transmembrane pH gradient -- 5.8 Membrane extrusion -- 5.9 Single pass -- 5.10 Handjani-vila -- 5.11 Heating -- 5.12 Freeze and thaw -- 5.13 Enzymatic -- 5.14 Microfluidic hydrodynamic focusing -- 5.15 Dehydration-rehydration -- 5.16 Supercritical carbon dioxide fluid (scCO2) -- 5.17 Lipid injection -- 5.18 Emulsion -- 5.19 Formation of niosomes from proniosomes -- 6. Methods for controlling the size of niosomes -- 6.1 Fractionation -- 6.2 Homogenization -- 6.3 Extrusion -- 7. Niosome purification -- 7.1 Dialysis -- 7.2 Reverse dialysis -- 7.3 Gel filtration/column chromatography -- 7.4 Centrifugation -- 7.5 Ultra-centrifugation -- 8. Characterization of niosomes -- 8.1 Size, morphology, and size distribution. , 8.2 Vesicular surface charge and zeta potential.

Additional Edition: Print version: Nayak, Amit Kumar Advanced and Modern Approaches for Drug Delivery San Diego : Elsevier Science & Technology,c2023 ISBN 9780323916684

Language: English

UID:

Format: 1 online resource (163 pages)

Edition: 2nd ed.

ISBN: 0-08-100714-0

Note: Bibliographic Level Mode of Issuance: Monograph , Front Cover -- Corrosion-Under-Insulation (CUI) Guidelines: Revised Edition -- Copyright -- Contents -- Volumes in the EFC series -- Introduction -- Chapter 1: Introduction -- 1.1 Purpose of document -- References -- Chapter 2:Economic consideration -- 2.1 Statistical analysis -- 2.2 Size of the issue -- 2.2.1 Safety and integrity -- 2.2.2 Environment -- 2.2.3 Revenue or production loss -- 2.2.4 Reputation -- 2.2.5 Collateral damage cost -- 2.2.6 On-line leak sealing cost -- 2.2.7 Repair/replacement, fabrication, and installation costs -- 2.2.8 Fitness for continued service -- 2.2.9 On-stream inspection and NDE/NDT -- 2.3 Key performance indicators -- Chapter 3:Ownership and responsibility -- 3.1 Senior management -- 3.2 Engineering manager -- 3.3 Maintenance -- 3.4 Operations -- 3.5 Inspection -- 3.6 Members of a project team: CUI program -- Chapter 4:The risk-based inspection methodology for CUI -- 4.1 Introduction -- 4.2 High-level prioritization -- 4.2.1 Health & -- safety consequences (A) -- 4.2.2 Environmental consequences (B) -- 4.2.3 Economic consequences (C) -- 4.2.4 Impact on reputation (D) -- 4.3 Data validation -- 4.3.1 The need for data validation -- 4.3.2 Different aspects of a data validation -- 4.3.3 Implementation of data validation -- 4.3.4 CUI and mothballing of equipment -- 4.4 Challenging the need for insulation -- 4.5 Using RBI to design CUI inspection plans -- 4.5.1 Preparation of an RBI analysis -- 4.5.2 Susceptibility factors -- 4.5.2.1 Operating temperature -- 4.5.2.2 Coating status -- 4.5.2.3 Cladding/insulation condition -- 4.5.2.4 Available corrosion allowance -- 4.5.2.5 External coil/steam tracing -- 4.5.2.6 External environment -- 4.5.3 Qualitative RBI analysis -- 4.5.4 Semiquantitative RBI analysis -- 4.5.4.1 Consequence of CUI failure. , 4.5.4.2 Probability of CUI failure -- 4.5.4.3 Risk of CUI failure -- References -- Chapter 5:Inspection activities/strategy -- 5.1 General considerations -- 5.2 Typical locations on piping circuits susceptible to CUI -- 5.3 Typical locations on equipment susceptible to CUI -- 5.3.1 Vessels, columns, and tanks -- 5.3.2 Heat exchangers -- 5.4 Examples of risk-based inspection plans -- 5.4.1 Evaluated risk level: High/extreme -- 5.4.2 Evaluated risk level: Medium-high -- 5.4.3 Evaluated risk level: Medium -- 5.4.4 Evaluated risk level: Low -- 5.4.5 Evaluated risk level: Negligible -- Chapter 6:Nondestructive examination and testing techniques for CUI -- 6.1 NDE/NDT techniques -- References -- Chapter 7:Recommended best practice to mitigate CUI -- 7.1 Background -- 7.1.1 Key parameters -- 7.1.2 Assumptions -- 7.2 Current CUI prevention methods -- 7.3 How to achieve a life expectancy of over 25 years -- 7.3.1 CUI preventive measures: Recent approaches -- 7.3.2 Material upgrade possibilities -- 7.4 Benefits of TSA -- 7.5 Use of personnel protective guards -- 7.6 Use of aluminum foil to mitigate Cl-ESCC of austenitic stainless steel -- References -- Chapter 8:Design for the prevention of CUI -- 8.1 Introduction -- 8.2 Challenge the requirement for insulation -- 8.3 Plant layout -- 8.4 Mechanical considerations: Equipment and tanks -- 8.5 Mechanical considerations: Piping -- 8.6 Materials of construction -- 8.7 Coatings and wrappings -- 8.7.1 Organic coatings -- 8.7.2 TSA coatings -- 8.7.3 Insulation coatings -- 8.7.4 Aluminum wrapping -- 8.8 Insulation system -- 8.9 Weatherproofing -- 8.10 Implementation -- References -- Appendix A: Cost: Economic evaluation -- Appendix B: Quality assurance -- Appendix C: Additional guidelines on the implementation of CUI best practice -- C.1 Maintenance and remediation issues. , C.1.1 Roles and responsibilities of maintenance and operations -- C.1.1.1 Maintenance -- C.1.1.2 Operations -- C.1.2 Safety considerations -- C.1.3 SHE concerns with asbestos and lead paint removal -- C.2 Minimum standards -- C.3 Types of insulation service -- C.3.1 Equipment in cyclic service -- C.3.2 Equipment in sweating service -- C.3.3 Equipment adjacent to cooling towers -- C.3.4 Equipment close to freezing point -- C.3.5 Deluge systems -- C.3.6 Steam tracing -- C.4 Surface preparation -- C.4.1 Overview -- C.4.2 Scaffolding -- C.4.3 Surface preparation -- C.4.4 Grit blasting -- C.4.5 Wet abrasion (jet cleaning) -- C.4.6 Water washing at pressure -- C.4.7 Wet abrasive blasting at low pressure -- C.4.8 Steam cleaning -- C.4.9 Vacuum blasting -- C.4.10 Mechanical surface preparation -- C.4.10.1 Mechanical brushing -- C.4.10.2 Descaling -- C.4.10.3 Pin hammer -- C.4.10.4 Sanding with grinding discs -- C.4.11 Nondust (vacuum) grit blast technology -- C.4.11.1 Sponge jet -- C.4.11.2 Solid carbon dioxide (CO 2) -- Appendix D: Coatings -- D.1 Introduction -- D.2 Protective coatings and protective coating selection -- D.3 Thermal spray aluminum -- D.4 Excerpt from NACE SP0198-2010 Section 4 protective coatings -- Appendix E: Application of thermal sprayed aluminum -- E.1 Thermal spray application -- E.1.1 Oxy-fuel wire spray-Flame spray -- E.1.2 Twin wire electric arc -- E.2 Use of organic topcoats -- E.3 Application strategies -- E.4 TSA specification -- E.5 Definitions -- E.6 Referenced codes, standards, and specifications -- E.7 Coating philosophy -- E.8 Coating system -- E.9 TSA material -- E.10 Seal coat -- E.11 Design -- E.12 Surface preparation -- E.13 Weather and surface conditions -- E.14 Application process -- E.15 Specific requirements for on-site TSA application -- E.16 Piping field welds. , E.17 Inspection and acceptance -- E.18 Documentation -- Appendix F Insulation material types and forms -- F.1 Mineral fiber -- F.2 Low density glass fiber -- F.3 Calcium silicate -- F.4 Cellular glass -- F.5 Ceramic fiber paper -- F.6 Glass rope insulation -- F.7 Self-setting cement -- F.8 Flexible reusable insulation cover mattresses -- F.9 Preformed rigid polyurethane foam (polyurethane-polyisocynaurate) -- F.10 Flexible elastomeric foam -- F.11 Flexible elastomeric foam ( EPDM) -- F.12 Polyethylene -- F.13 Perlite -- F.14 Vermiculite -- Appendix G: Cladding/jacketing materials -- G.1 Metallic cladding materials -- G.1.1 Aluminized steel sheeting -- G.1.2 Aluminum-zinc coated sheeting -- G.1.3 Galvanized steel sheeting -- G.1.4 Stainless steel jacketing -- G.1.5 Aluminum sheeting -- G.2 Nonmetallic materials -- G.2.1 UV -cured, fiber-reinforced materials -- G.2.2 Chlorosulfonated polyethylene -- Appendix H: Use of protection guards -- H.1 Design considerations -- H.2 Method guidance notes -- Appendix I: NDE/NDT techniques -- I.1 Visual inspection -- I.2 Manual ultrasonic thickness measurement through inspection openings -- I.3 Radiography -- I.3.1 Profile radiography -- I.3.2 Flash radiography -- I.4 Real-time radiography -- I.5 Guided wave ultrasonic measurements -- I.6 Pulsed eddy current -- I.7 Digital radiography -- I.8 Infrared thermography -- I.9 Neutron backscatter -- I.10 Dye penetrant testing -- Index -- Back Cover. , English

Language: English

UID:

Format: 1 online resource (379 pages)

ISBN: 9780443186172

Series Statement: Heterocyclic Drug Discovery

Content: Fused Pyrimidine-Based Drug Discovery covers all categories of fused-pyrimidines along with pharmacological and in silico studies. It covers the chemistry and biological activities, as well as the design of novel fused-pyrimidine scaffolds. N-Heterocyclic scaffolds are found in most known drug candidates, and are of interest to medicinal and organic chemists to design, synthesize and evaluate their biological properties. A variety of fused-pyrimidine molecules have been synthesized and extracted from natural resources, and are found to exhibit various biological activities such as antifolates, anticancer agents, analgesics, antimetabolites, CNS active agents and many more. Some of these scaffolds like purines are also known to have involvement in biological processes and are part of the framework of genetic material. This book focuses on the classification, structural chemistry, and chemical and physical properties along with various approaches for their synthesis.

Note: Front Cover -- Fused Pyrimidine-Based Drug Discovery -- Fused Pyrimidine-Based Drug Discovery Heterocyclic Drug Discovery -- Copyright -- Contents -- Contributors -- Biographies -- Foreword -- Foreword -- Foreword -- Acknowledgments -- 1 - Introduction -- 1.1 Introduction -- References -- 2 - FDA approved fused pyrimidine-based drugs -- 2.1 Introduction -- 2.2 Fused pyrimidine-based anticancer drugs -- 2.3 Fused pyrimidine-based drugs as anti-viral agents -- 2.4 Fused pyrimidine-based drugs for cardiovascular disorders -- 2.5 Fused pyrimidine-based drugs for respiratory disorders -- 2.6 Fused pyrimidine-based drugs for inflammatory diseases -- 2.7 Fused pyrimidine-based drugs for neurological disorders -- 2.8 Fused pyrimidine-based drugs for treatment of benign prostatic hypertrophy (BPH) -- 2.9 Fused pyrimidine-based drugs for treatment of erectile dysfunction -- 2.10 Fused pyrimidine-based drugs for miscellaneous use -- 2.11 Analysis of the approved drugs -- References -- 3 - Naturally occurring fused pyrimidine derivatives and their medicinal attributes -- 3.1 Introduction -- 3.1.1 Fused pyrimidine from plants -- 3.1.2 Fused pyrimidine derivatives from fungi -- 3.1.3 Fused pyrimidine derivatives obtained from sponges -- References -- 4 - Five-membered ring fused pyrimidine-based derivatives and their biological properties -- 4.1 Introduction -- 4.2 Pyrazolo[3,4-d]pyrimidine -- 4.2.1 Anticancer activity -- 4.2.2 α-amylase and α-glucosidase inhibitors -- 4.2.3 Anti-inflammatory activity -- 4.2.4 Antibacterial activity -- 4.3 Pyrrolo[1,2-c]pyrimidines, pyrrolo[2,3-d]pyrimidines and pyrrolo[3,2-d]pyrimidines -- 4.3.1 PI3Kα inhibitors -- 4.3.2 Antitumor agents -- 4.4 Thieno[2,3-d]pyrimidines and thieno[3,2-d]pyrimidines -- 4.4.1 DNase I inhibition activity -- 4.4.2 Anti-proliferative activity -- 4.5 Furo[3,2-d]pyrimidines and related heterocycles. , 4.5.1 G-protein coupled receptor (GPCR)119 agonists -- 4.5.2 Anti-cancer agents -- 4.5.3 Anti-HCV activity -- 4.5.4 Epidermal growth factor receptor (EGFR) inhibitors -- 4.6 Triazolo[1,5-a]pyrimidines, pyrazolo[1,5-a]pyrimidines, and pyrimido[1,2-a]benzimidazoles -- 4.6.1 Anti-cancer activity -- 4.6.2 Antitubercular activity -- 4.7 Pyrazolothienopyrimidine -- 4.8 Thiazolo[3,2-a]pyrimidines -- 4.8.1 Antimicrobial activity -- 4.8.2 Anticancer activity -- 4.8.3 Anti-inflammatory agents -- 4.8.4 Antibacterial and antitubercular agents -- 4.9 Thiazolo[4,5-d]pyrimidines -- 4.9.1 Cyclooxygenase inhibitors -- 4.10 Pyrido[4',3':4,5]thieno[2,3-d]pyrimidines -- 4.11 Recent patents -- Acknowledgments -- References -- 5 - FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties -- 5.1 Sildenafil -- 5.2 Valganciclovir -- 5.3 Duvelisib -- 5.4 Vidarabine -- 5.5 Abacavir -- 5.6 Entecavir -- 5.7 Ganciclovir -- 5.8 Acyclovir -- 5.9 Theophylline -- 5.10 Pemetrexed -- 5.11 Zanubrutinib -- 5.12 Cangrelor -- 5.13 Ticagrelor -- 5.14 Fludarabine -- 5.15 Valaciclovir -- 5.16 Nelarabine -- 5.17 Cladribine -- 5.18 Istradefylline -- 5.19 Penciclovir -- 5.20 Tofacitinib -- 5.21 Ribociclib -- 5.22 Tenofovir alafenamide -- 5.23 Ibrutinib -- 5.24 Udenafil -- 5.25 Allopurinol -- 5.26 Ruxolitinib -- 5.27 Baricitinib -- 5.28 Zaleplon -- 5.29 Azathioprine -- 5.30 Thioguanine -- 5.31 Anagliptin -- 5.32 Regadenoson -- 5.33 Adefovir dipivoxil -- 5.34 Clofarabine -- 5.35 Idelalisib -- 5.36 Didanosine -- 5.37 Famciclovir -- 5.38 Dyphylline -- 5.39 Pentoxifylline -- 5.40 Caffeine -- 5.41 Enprofylline -- References -- 6 - Benzene fused pyrimidine-based derivatives and their biological properties -- 6.1 Preface -- 6.2 Zorifertinib (AZD3759) -- 6.3 CZh226 -- 6.4 2-amino-4-methylquinazoline derivatives. , 6.5 (S)-3-((2-amino-8-fluoroquinazolin-4-yl)amino)hexan-1-ol -- 6.6 7-methoxy-4-(2-methylquinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-one -- 6.7 BMS-919373 -- 6.8 1-(4-((3-Chlorophenyl)amino)quinazolin-6-yl)-3-(3,5- difluorophenyl)thiourea -- 6.9 N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)- phenyl)-2-(pyridin-4-yl)quinazolin-4-amine -- 6.10 GSK2983559 -- References -- 7 - Six-membered ring (with N, O or S) fused pyrimidine-based derivatives and biological properties -- 7.1 Introduction -- 7.2 Classification -- 7.2.1 Nitrogen-containing six-membered rings fused with pyrimidine -- 7.2.1.1 Pyrido-pyrimidines -- 7.2.1.1.1 Pyrido[3,4-d]pyrimidines -- 7.2.1.1.2 Pyrido[2,3-d]pyrimidines -- 7.2.1.1.3 Pyrido[3,2-d]pyrimidines -- 7.2.1.1.4 Pyrido[4,3-d] pyrimidines -- 7.2.1.2 Pyrimidopyrimidines -- 7.2.1.2.1 Pyrimidio[1,6-a] and [1,6-c]pyrimidines -- 7.2.1.2.2 Pyrimido[4,5-d]pyrimidines -- 7.2.1.2.3 Pyrimido[5,4-d]Pyrimidines -- 7.2.1.2.4 Pyrimido[1,2-a]pyrimidines -- 7.2.1.3 Pteridine -- 7.2.2 Oxygen-containing six-membered ring fused with pyrimidine -- 7.2.2.1 Chromeno[2,3-d]pyrimidines -- 7.2.2.2 Pyrano[3,2-d]pyrimidines -- 7.2.2.3 Pyrano[2,3-d]pyrimidines -- 7.2.3 Sulphur containing six-membered rings fused with a pyrimidine -- 7.2.3.1 Thiopyrano[3,2-d]pyrimidines -- References -- 8 - FDA approved six-membered ring fused pyrimidine-based derivatives -- 8.1 Methotrexate -- 8.2 Risperidone -- 8.3 Pemirolast -- 8.4 Pralatrexate -- 8.5 Trametinib -- 8.6 Triamterene -- 8.7 Palbociclib -- 8.8 Dipyridamole -- 8.9 Prazosin -- 8.10 Alfuzosin -- 8.11 Trimetrexate -- 8.12 Anagrelide -- 8.13 Quinethazone -- 8.14 Copanlisib -- 8.15 Terazosin -- 8.16 Doxazosin -- 8.17 Gefitinib -- 8.18 Erlotinib -- 8.19 Afatinib -- 8.20 Dacomitinib -- 8.21 Vandetanib -- 8.22 Lapatinib -- 8.23 Idelalisib -- 8.24 Raltitrexed -- 8.25 Asasantin -- References. , 9 - Seven-membered ring fused pyrimidine-based derivatives and their biological properties -- 9.1 Introduction -- 9.2 Pyrimidine fused with a seven-membered ring containing nitrogen -- 9.3 Pyrimidine fused with a seven-membered ring containing oxygen -- 9.4 Pyrimidine fused with a seven-membered ring containing nitrogen and oxygen -- 9.5 Pyrimidine fused with a seven-membered ring containing sulphur -- 9.6 Pyrimidine fused with a seven-membered ring containing nitrogen and sulfur -- References -- 10 - Eight-membered fused pyrimidine derivatives and their biological properties -- 10.1 Introduction -- 10.2 Exploring the reported literature on eight-membered heterocycles fused with a pyrimidine ring -- 10.3 Tricyclic pyrimidine-fused eight-membered diazocines -- 10.3.1 Eight-membered rings (azocine) -- 10.4 Conclusion -- References -- 11 - Molecular modeling studies of fused pyrimidine derivatives at various receptors -- 11.1 Abacavir -- 11.1.1 Mechanism of action -- 11.1.2 Binding mode analysis -- 11.2 Acyclovir -- 11.2.1 Mechanism of action -- 11.2.2 Binding mode analysis -- 11.3 Adefovir dipivoxil -- 11.3.1 Mechanism of action -- 11.3.2 Binding mode analysis -- 11.4 Allopurinol -- 11.4.1 Mechanism of action -- 11.4.2 Binding mode analysis -- 11.5 Anagliptin -- 11.5.1 Mechanism of action -- 11.5.2 Binding mode analysis -- 11.6 Azathioprine -- 11.6.1 Mechanism of action -- 11.6.2 Binding mode analysis -- 11.7 Baricitinib -- 11.7.1 Mechanism of action -- 11.7.2 Binding mode analysis -- 11.8 Caffeine -- 11.8.1 Mechanism of action -- 11.8.2 Binding mode analysis -- 11.9 Cangrelor -- 11.9.1 Mechanism of action -- 11.9.2 Binding mode analysis -- 11.10 Cladribine -- 11.10.1 Mechanism of action -- 11.10.2 Binding mode analysis -- 11.11 Clofarabine -- 11.11.1 Mechanism of action -- 11.11.2 Binding mode analysis -- 11.12 Didanosine. , 11.12.1 Mechanism of action -- 11.12.2 Binding mode analysis -- 11.13 Dipyridamole -- 11.13.1 Mechanism of action -- 11.13.2 Binding mode analysis -- 11.14 Duvelisib -- 11.14.1 Mechanism of action -- 11.14.2 Binding mode analysis -- 11.15 Dyphylline -- 11.15.1 Mechanism of action -- 11.15.2 Binding mode analysis -- 11.16 Enprofylline -- 11.16.1 Mechanism of action -- 11.16.2 Binding mode analysis -- 11.17 Entecavir -- 11.17.1 Mechanism of action -- 11.17.2 Binding mode analysis -- 11.18 Fludarabine -- 11.18.1 Mechanism of action -- 11.18.2 Binding mode analysis -- 11.19 Ganciclovir -- 11.19.1 Mechanism of action -- 11.19.2 Binding mode analysis -- 11.20 Ibrutinib -- 11.20.1 Mechanism of action -- 11.20.2 Binding mode analysis -- 11.21 Idelalisib -- 11.21.1 Mechanism of action -- 11.21.2 Binding mode analysis -- 11.22 Istradefylline -- 11.22.1 Mechanism of action -- 11.22.2 Binding mode analysis -- 11.23 Methotrexate -- 11.23.1 Mechanism of action -- 11.23.2 Binding mode analysis -- 11.24 Nelarabine -- 11.24.1 Mechanism of action -- 11.24.2 Binding mode analysis -- 11.25 Palbociclib -- 11.25.1 Mechanism of action -- 11.25.2 Binding mode analysis -- 11.26 Pemetrexed -- 11.26.1 Mechanism of action -- 11.26.2 Binding mode analysis -- 11.27 PEMIROLAST -- 11.27.1 Mechanism of action -- 11.27.2 Binding mode analysis -- 11.28 Penciclovir -- 11.28.1 Mechanism of action -- 11.28.2 Binding mode analysis -- 11.29 Pentoxifylline -- 11.29.1 Mechanism of action -- 11.29.2 Binding mode analysis -- 11.30 Pralatrexate -- 11.30.1 Mechanism of action -- 11.30.2 Binding mode analysis -- 11.31 Regadenoson -- 11.31.1 Mechanism of action -- 11.31.2 Binding mode analysis -- 11.32 Ribociclib -- 11.32.1 Mechanism of action -- 11.32.2 Binding mode analysis -- 11.33 Risperidone -- 11.33.1 Mechanism of action -- 11.33.2 Binding mode analysis -- 11.34 Ruxolitinib. , 11.34.1 Mechanism of action.

Additional Edition: Print version: Kumar, Raj Fused Pyrimidine-Based Drug Discovery San Diego : Elsevier,c2022 ISBN 9780443186165

Language: English

UID:

Format: 1 online resource (270 pages) : , illustrations, tables.

Edition: 1st edition

ISBN: 0-08-101231-4

Series Statement: Chandos Information Professional Series

Content: Overcoming Information Poverty: Investigating the Role of Public Libraries in The Twenty-First Century considers the role of public libraries in alleviating information poverty and targeting social exclusion, using a three-level information poverty framework. The book proposes a model for understanding the concept of information poverty, develops indicators for its measurement, and provides recommendations for service improvement based on analysis of public library services at macro (strategic), meso (community) and micro (individual) levels. The topic is of theoretical and practical importance when considering the changing role of public libraries today. The book is the first time a macro, meso, and micro model of information poverty indicators has been developed and applied to illustrate the impact of public libraries at strategic, community, and personal levels. Stimulates thinking and debate on information poverty and how it may be addressed by public libraries, education departments, and governments Uses case studies to investigate how information poverty can be tackled at the macro, meso, and micro level Focuses on how strategic policies to reduce information poverty filter through to community-based interventions within branch libraries Discusses mixed methods, using quantitative and qualitative data, surveys, interviews, and focus groups with library users and non-users, to conduct a three-level investigation of information poverty

Note: Front Cover -- OVERCOMING INFORMATION POVERTY -- Series Page -- OVERCOMING INFORMATION POVERTY: Investigating the Role of Public Libraries in The Twenty-First Century -- Copyright -- CONTENTS -- LIST OF FIGURES -- LIST OF TABLES -- PREFACE -- ACKNOWLEDGEMENTS -- ABBREVIATIONS -- 1 - Introduction -- 1.1 INTRODUCTION -- 1.2 BACKGROUND AND RATIONALE -- 1.3 INFORMATION POVERTY -- 1.4 A NEW PERSPECTIVE ON INFORMATION POVERTY AND PUBLIC LIBRARIES -- 1.5 THE MACRO, MESO AND MICRO FRAMEWORK -- 1.6 RESEARCH DESIGN AND METHODOLOGY: LIBRARIES NI AS THE CASE STUDY -- 1.6.1 Stage 1 Data Collection Methods: Macro Level -- 1.6.2 Stage 2: Meso-Level Questionnaire and Interviews -- 1.6.3 Stage 3: Focus Groups (Micro Level) -- 1.7 STRUCTURE OF THE BOOK -- 1.8 SUMMARY -- 2 - Setting the Context -- 2.1 INTRODUCTION -- 2.2 HISTORICAL CONTEXT: PUBLIC LIBRARIES AND SOCIAL INCLUSION -- 2.3 POVERTY IN NORTHERN IRELAND -- 2.4 THE DEPARTMENT FOR CULTURE, ARTS AND LEISURE AND LIBRARIES NI -- 2.5 LIBRARY USAGE IN NORTHERN IRELAND -- 2.6 LIBRARY USAGE IN SOCIALLY DEPRIVED AREAS -- 2.7 CONCLUSIONS -- 3 - Developing an Understanding of What Information Poverty Is -- 3.1 INTRODUCTION -- 3.2 CONCEPTUALISING 'INFORMATION' -- 3.2.1 The Importance of Information -- 3.3 POVERTY AND INFORMATION POVERTY -- 3.4 ORIGINS OF THE CONCEPTS OF 'INFORMATION POVERTY' AND THE 'INFORMATION POOR' -- 3.5 INFORMATION POVERTY AND THE INFORMATION POOR IN THE LIS DISCOURSE -- 3.6 INFORMATION POVERTY: PERSPECTIVES FROM POLICY MAKERS AND LIBRARY STAFF -- 3.7 INFORMATION POVERTY AND SOCIAL EXCLUSION -- 3.8 UNITED KINGDOM GOVERNMENT: ACCESS TO INFORMATION AND PUBLIC LIBRARIES -- 3.9 CONCLUSIONS -- 4 - Factors Creating Information Poverty -- 4.1 INTRODUCTION -- 4.2 FACTORS CREATING INFORMATION POVERTY -- 4.3 PHYSICAL ACCESS TO INFORMATION: INFRASTRUCTURAL APPROACHES. , 4.4 SOCIAL FACTORS CREATING INFORMATION POVERTY -- 4.5 AWARENESS OF INFORMATION -- 4.6 FINANCIAL FACTORS CREATING INFORMATION POVERTY -- 4.7 EDUCATIONAL FACTORS CREATING INFORMATION POVERTY -- 4.8 THE SKILLS NEEDED TO ACCESS INFORMATION -- 4.9 BARRIERS TO LIBRARY USAGE -- 4.10 PERSONAL FACTORS CREATING INFORMATION POVERTY -- 4.11 INTELLECTUAL AND COGNITIVE FACTORS CREATING INFORMATION POVERTY -- 4.12 VIEWING INFORMATION POVERTY AS A CONTINUUM -- 4.13 INFORMATION POVERTY INDICATORS -- 4.14 INFORMATION POVERTY INDICATORS AND PUBLIC LIBRARIES -- 4.15 MEASURING THE IMPACT OF PUBLIC LIBRARY SERVICES -- 4.16 A THREE-LEVEL MODEL OF INFORMATION POVERTY -- 4.17 CONCLUDING THOUGHTS -- 5 - Investigating Information Poverty at the Macro Level: Part 1 -- 5.1 INTRODUCTION -- 5.2 MACRO-LEVEL APPROACHES TO INFORMATION POVERTY -- 5.3 DIGITAL INCLUSION: THE DIGITAL BY DEFAULT AGENDA -- 5.3.1 Digital by Default and Public Libraries -- 5.3.2 Public Libraries and Supporting Digital Inclusion -- 5.4 NORTHERN IRELAND HOME ICT AND INTERNET ACCESS -- 5.5 ACCESS TO INFORMATION: INFRASTRUCTURE -- 5.5.1 Access to Information: Strategic Partnerships for Digital and Social Inclusion -- 5.5.2 Strategic Partnerships to Address Information Poverty -- 5.6 TACKLING POVERTY AND SOCIAL EXCLUSION: THE TSE STRATEGY -- 5.7 STAFF SKILLS TO TACKLE SOCIAL AND DIGITAL EXCLUSION -- 5.8 CONCLUSIONS -- 6 - Information Poverty at the Macro Level: Part 2 -- 6.1 INTRODUCTION -- 6.2 LIFELONG LEARNING AND PUBLIC LIBRARIES -- 6.3 SUPPORTING LEARNING: DEVELOPING LITERACY SKILLS -- 6.3.1 Literacy Levels in Northern Ireland -- 6.3.2 Literacy, Developing Readers and Supporting Families -- 6.3.3 Supporting Literacy: The Role of Public Library Staff -- 6.4 PUBLIC LIBRARIES AND CULTURAL INCLUSION -- 6.5 INFORMATION LITERACY SKILLS AND PUBLIC LIBRARIES. , 6.5.1 Information Literacy: Perspectives From Macro-Level Interviewees -- 6.6 DIGITAL LITERACY -- 6.6.1 Developing Digital Literacy Skills -- 6.6.2 Developing Digital Literacy Skills: Examples From Northern Ireland -- 6.7 MAPPING THE INFORMATION POVERTY INDICATORS FRAMEWORK TO LIBRARIES NI'S INFORMATION PROVISION AND SERVICES -- 6.8 SUMMARY AND CONCLUSIONS -- 7 - Investigating Information Poverty at the Meso Level: Part 1 -- 7.1 INTRODUCTION -- 7.2 LOCALISED INFORMATION ENVIRONMENTS -- 7.3 INFORMATION SEEKING WITHIN DISADVANTAGED COMMUNITIES -- 7.4 CHATMAN'S INFORMATION POVERTY THEORIES -- 7.5 CHATMAN'S SMALL-WORLD THEORIES AND PUBLIC LIBRARIES -- 7.6 SOCIAL PARTICIPATION -- 7.7 STRONG TIES/WEAK TIES THEORY AND PUBLIC LIBRARIES -- 7.8 PUBLIC LIBRARIES AS THIRD PLACES SUPPORTING INFORMATION SHARING -- 7.9 SUMMARY AND CONCLUSIONS -- 8 - Investigating Information Poverty at the Meso Level: Part 2 -- 8.1 INTRODUCTION -- 8.2 CHALLENGES FACING LIBRARY MANAGERS IN SOCIALLY DEPRIVED AREAS -- 8.3 COMMUNITY PARTNERSHIPS -- 8.4 GROUPS THAT PUBLIC LIBRARIES COULD TARGET MORE EFFECTIVELY -- 8.5 LIBRARY SERVICES AND THE ELDERLY -- 8.6 LIBRARY SERVICES TO THE DISABLED -- 8.7 OUTREACH TO THE HOMELESS -- 8.8 ENGAGEMENT WITH LONE PARENTS -- 8.9 IMPROVING COMMUNITY OUTREACH -- 8.10 CONCLUSIONS -- 9 - Investigating Information Poverty at the Micro Level -- 9.1 INTRODUCTION -- 9.2 PUBLIC LIBRARIES AND THE UNEMPLOYED -- 9.3 FOCUS GROUP 1: YOUNG PEOPLE AGED 18-24YEARS (NEET) -- 9.3.1 Resources and Support at the Community Centre -- 9.3.2 ICT/Internet Access and Skills and Qualifications -- 9.3.3 Use of the Local Library -- 9.3.4 Reading -- 9.3.5 Making Public Libraries More Appealing to Young People -- 9.3.6 Extracting Information Poverty Indicators From the Community Centre Focus Group 1 -- 9.3.7 Focus Group 1: Key Findings -- 9.4 JOB CLUBS IN LIBRARIES. , 9.5 FOCUS GROUP 2: THE LIBRARY JOB CLUB -- 9.5.1 Library Usage -- 9.5.2 Benefits of the Library Job Club -- 9.5.3 Extracting Information Poverty Indicators From the Library Job Club Focus Group -- 9.5.4 Focus Group 2: Key Findings -- 9.6 LEARNING FROM OTHER LOCATIONS -- 9.7 SUMMARY AND CONCLUSIONS -- 10 - Concluding Thoughts and Recommendations -- 10.1 INTRODUCTION -- 10.2 SUMMING UP -- 10.3 FUTURE CHALLENGES FOR PUBLIC LIBRARIES -- 10.4 RECOMMENDATIONS FOR POLICY AND PRACTICE -- 10.4.1 Recommendation 1: Develop an Information Poverty Strategy -- 10.4.2 Recommendation 2: Develop and Implement a Community Engagement Strategy -- 10.4.3 Recommendation 3: Further Develop the Educational Role of Public Libraries -- 10.4.4 Recommendation 4: Further Develop the Social Role of Public Libraries -- 10.4.5 Recommendation 5: Raising Awareness and Marketing -- 10.4.6 Recommendation 6: Identifying and Targeting Groups -- 10.4.7 Recommendation 7: Developing Services for the Unemployed -- 10.4.8 Recommendation 8: Improving Stock -- 10.4.9 Recommendation 9: Library Staff -- 10.5 CONCLUDING THOUGHTS -- APPENDICES -- APPENDIX 1: MACRO- AND MESO-LEVEL INTERVIEWEES -- APPENDIX 2: SURVEY QUESTIONS -- APPENDIX 3: INFORMATION POVERTY INDICATORS FROM THE MACRO-LEVEL DATA -- APPENDIX 4: THE 20 MOST CITED INDICATORS OF INFORMATION POVERTY IN THE LITERATURE -- REFERENCES -- INDEX -- A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- S -- T -- U -- W -- Z -- Back Cover.

Additional Edition: ISBN 0-08-101110-5

Language: English